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Despite significant efforts to improve the clinical performance (e.g. mechanical and 
remineralizing properties) of glass ionomer cements (GICs), their essential characteristics such as 
proper translucency, adhesion to enamel and dentine, and fluoride-releasing capability cannot yet 
be fully exploited in load-bearing areas in restorative dentistry. The aim of this study is to introduce 
a functional approach to improve not only the mechanical properties of GICs, but also to enhance 
their biomineralizing capacity.  
In the first stage of this study, a series of versatile heat treatment profiles are used to tailor 
the crystallinity of 45S5 Bioglass® within a wide range of 5% to 100% via the formation of solely 
combeite as a mechanically competent yet bioactive phase. The resulting 45S5 glass-ceramics 
containing combeite not only are expected to retain beneficial levels of bioactivity, but also show 
improved mechanical properties compared to those of the amorphous 45S5 Bioglass®. By choosing 
the proper heat treatment from the proposed profiles in this study, different levels of mechanical 
properties and bioactivity in Bioglass® can be achieved according to the target application(s).  
In the second stage of this study, hybrid GICs with enhanced mechanical and 
remineralizing properties were developed via incorporation of an optimum amount (5 wt%) of 
45S5 Bioglass®-ceramic particles with a certain degree of crystallinity. The effect of the degree of 
crystallinity of additives, which is completely overlooked in the current literature, was also 
addressed in this study. Mechanical properties testing, in vitro studies and microstructural analysis 
iv 
 
revealed that the Bioglass®-ceramic particles with 74% crystallinity best act as both remineralizing 
and reinforcing agents. Enhanced remineralizing and mechanical properties may not only broaden 
the hybrid GICs’ clinical applications but also can potentially enhance their in vivo performance. 
In the last stage of this study, a novel aluminum-free, 45S5 Bioglass®-based GIC with 
standard mechanical properties was produced. For the first time, 45S5 Bioglass® and its Bioglass®-
ceramic were used as the GIC solid component. The Bioglass®-ceramic particles with 74% 
crystallinity was used as they favorably act as both remineralizing and reinforcing agents. The 
early stage progression of setting reaction was monitored. Bimodal particle size distribution was 
shown to improve the packing density and integrity of the set cement. In such GICs, not only the 
neurotoxicity of Al is eliminated, but chemical bond formation at cement/hard tissue(s) interface 
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1 Chapter 1 
 
1.1 Overview 
Two of the most fascinating fields in science today are materials science and biomedicine. 
Biomedicine is an area of science with extremely high rate of growth of knowledge that seeks 
improved medical solutions to the endless human need for curing the disease. On the other hand, 
materials science and engineering is one of the most thriving disciplines in modern applied science 
that has produced a massive deal of technology since its introduction after World War II. Over the 
past half century, materials science has constantly and progressively redeveloped itself into new 
territories.  
Inevitably, the interface between these two fields of science is drawing enormous attention 
to research community as materials science can be applied to functionally address the existing 
problems in biomedicine. Resulting from this ever-growing attention, biomaterials science has 
been emerged as a substantial new branch of materials science.  
Biomaterials can imperfectly yet functionally replace limited number of biological 
structures. Dental restoratives are among those functional replacements that are used as a treatment 
to resume hard tissue of teeth masticatory function as well as its aesthetic effects resulting from 
caries. Glass ionomer cements (GICs) are a major class of dental restorative materials that offer 
an outstanding combination of properties. However, similar to other functional replacement 
biomaterials, they are imperfect. They suffer mainly from poor mechanical properties as well as 
low remineralizing capacity which have restrained their high demanding potential. The aim of this 
study is to enhance not only the mechanical properties of GICs, but also to improve their 




The main objectives of each step of this study are presented according to the sequence of 
chapters in this thesis. 
➢ To develop a set of controlled and comprehensive heat treatment profiles to tailor the 
crystallinity of 45S5 Bioglass® within a wide range of 5% to 100% via the formation of 
solely combeite which is a mechanically strong and bioactive crystalline phase. (presented 
in Chapter 3) 
➢ To produce 45S5 Bioglass®-ceramic particles with optimum degree of crystallinity 
(containing only combeite) as reinforcing agent for GICs. (presented in Chapter 4) 
➢ To develop hybrid GICs with improved mechanical and remineralizing properties via the 
incorporation of an optimum amount of 45S5 Bioglass®-ceramic with optimum degree of 
crystallinity as reinforcing agent. (presented in Chapter 4) 
➢ To produce a novel aluminum-free GIC consisting of 45S5 Bioglass® and polyacrylic acid 
aqueous solution with appropriate mechanical performance and potentially enhanced 
remineralizing and adhesion properties comparable to commercially available GICs. 
(presented in Chapter 5) 
1.3 Thesis organization 
 This thesis contains six chapters which are briefly described here. Chapter 1 provides the 
overview and objectives of the investigation. Chapter 2 presents the literature review on dental 
restorative materials; in particular glass ionomer cements (GICs). The chemical composition and 
setting reaction of these materials as well as their mechanical and physical properties are discussed 
in detail and various attempts to overcome their drawbacks are also reviewed. Furthermore, 
bioactive glasses, particularly 45S5 Bioglass®, and glass-ceramics are reviewed.  
Chapter 3 provides an understanding about the crystallization behavior of 45S5 Bioglass® 
through controlled heat treatment. The steps involved in controlling the nucleation and growth 
temperatures and times of combeite phase resulting in the development of heat treatment regimes 
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to tailor the crystallinity of 45S5 glass-ceramics by the formation of combeite over a wide range 
of 5% to 100% to are discussed. Also, in this chapter the activation energy for crystallization of 
combeite and the Avrami exponent of the 45S5 Bioglass® powder are investigated and calculated 
using various classic thermal analysis approaches. 
Chapter 4 focuses on the development of hybrid GICs with improved mechanical and 
remineralizing properties through incorporation of 45S5 Bioglass®-ceramic particles. 45S5 
Bioglass® crystallization to various degrees of crystallinities using suitable heat treatments 
developed in the previous chapter is discussed. The approaches to finding the optimum degree of 
crystallinity which provides the highest mechanical performance are explored and the mechanical 
properties of the incorporated hybrid GICs are assessed. Furthermore, the active strengthening 
mechanisms involved are discussed using fractography. Also, an in vitro study in simulated body 
fluid (SBF) is conducted to investigate the biomineralizing properties of the hybrid GICs. 
In Chapter 5, a novel aluminum-free 45S5 Bioglass®-based GIC with standard mechanical 
properties is introduced. In this chapter, 45S5 Bioglass® and its Bioglass®-ceramic as the only 
solid component of the experimental GIC is studied. The microstructure of fractured surfaces is 
also investigated to study the strengthening mechanisms involved. Also, the progression of the 
setting reaction at the early stages of setting is monitored. 
Chapter 6 summarizes the conclusions and contributions of this research and proposes a 
list of recommendations for future studies.  
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2 Chapter 2 
2.1 Direct dental restorative materials 
Direct dental restorative materials are a substantial yet complicated part of the modern 
restorative dentistry which are extensively used to restore the lost tooth functions caused by cavity 
formation [1]. Whilst the proper mechanical and chemical performance of these materials (i.e. 
strength and biocompatibility1) are the primary goals, aesthetics considerations are also of high 
demand as patients are concerned with cosmetic aspects of teeth restoration as much as 
performance [2]. Currently, the three main clinically available direct restorative materials are 
amalgams, resin composite and glass ionomer cement (GIC) [3]. 
Amalgam is a direct restorative that is held in place by mechanical retention which results in 
highly invasive tooth repair. It is prepared by mixing powders of Ag-Sn alloy with liquid mercury. 
For the past 150 years, amalgam has been widely used in dentistry due to its strength, durability, 
low cost and bacteriostatic effect [4]. However, they offer poor aesthetics and no adhesive 
properties. Therefore, today's dentistry is showing a strong tendency to move away from metal 
restorations towards tooth-colored non-metal ones [5].  
Resin composite is prepared by mixing of an inorganic filler and an organic liquid to make a 
paste which is used to fill the tooth cavity [6]. The resulting paste can either be cured through self-
initiation or light-initiation to polymerize the monomers and create a three-dimensional solid 
matrix containing dispersed filler particles. A variety of inorganic filler types can be used in resin 
composites including borosilicate glass, quartz, lithium/barium aluminum silicate glass, and 
borosilicate glass containing zinc/strontium/lithium [4].  
Before discussing the properties and structure of GICs in section 2.2, a brief history of dental 
cements will be presented.  
 
 
1 Biocompatibility is defined as the ability of a material to perform with an appropriate host response in a system [1]. 
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In majority of the restorative dental history, silver amalgam and gold foils were predominantly 
used for functional repair of the tooth. In 1855, the first dental cement, namely zinc oxychloride 
was introduced resulting from reaction of zinc oxide powder with aqueous solution of zinc 
chloride. Even though this cement had poor clinical performance (e.g. manipulation difficulty and 
high erosion rate), it was at least white and more matching to the appearance of the tooth compared 
to its metallic counterparts [7].  
Zinc phosphate cement was invented next. When first formulated in 1878, it was not clinically 
popular due to excessively exothermic setting reaction between zinc oxide and aqueous phosphoric 
acid. Modifications were made to both components in 1902 to control the setting reaction and 
decrease the heat generated [1]. Due to its good handling properties, appealing aesthetics and 
appropriate dimensional stability, the modified zinc phosphate cement still provides great service 
in clinical dentistry, particularly for luting crowns [8].  
The third developed dental cement is silicate cement which was the most clinically important 
one among the three. It also paved the road to development of glass ionomer cements (GICs). The 
first competent version of silicate cement appeared in 1908 consisting of a i.e. fluoride-containing 
calcium aluminosilicate glass and a liquid i.e. concentrated solution of phosphoric acid [9]. The 
resulting material was an off-white paste with proper workability which sets quickly to a strong 
translucent mass. Silicate cements offered three main advantages over zinc phosphate cements: 1) 
translucency which made them suitable for aesthetic tooth repair, 2) therapeutic benefit of 
sustained fluoride release, and 3) higher compressive strength [10]. Despite all these advantages 
that made them the only tooth-colored dental restorative available until the mid-1950’s [11]. They 
had a number of drawbacks including vulnerability against acids (e.g. citric acid) in oral 
environment, a porous structure, tendency to stain, poor dimensional stability and insufficient 
adhesion to the tooth [10]. 
In early 1960’s when the Laboratory of the Government Chemist in the UK was investigating 
silicate cements searching for potential improvements [12], it was realized that the range of 
optimum performance for silicate cements was relatively narrow and they had hardly any potential 
scope for chemical variation. However, these findings led to a series of innovative steps which 
eventually led to development of other dental cements [13]. In 1968, zinc polycarboxylate cement 
was invented from the reaction of zinc oxide with aqueous solution of polyacrylic acid. It was the 
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first time that a weak organic acid was used in making a dental cement. Zinc polycarboxylate 
cement represent a big step forward in restorative dentistry as it was the first cement to show 
inherent adhesion to the tooth surface. It remains a functional material in clinical dentistry and is 
used as a liner/base, luting cement and periodontal dressing1 [10].  
Glass ionomer cements will be reviewed in the following section (2.2). 
2.2 Glass ionomer cements 
Wilson and Kent invented glass ionomer cements in 1969 in Laboratory of the Government 
Chemist in the UK by combining the benefits of two existing dental restoratives namely zinc 
polycarboxylate cement and silicate cement [14]. For the past 50 years GICs have remained a key 
class of dental restorative materials [9] due to their unique combination of properties. They can 
form direct chemical bonding to untreated dentin and enamel allowing a desirable seal of the 
cavity. They also offer anticariogenic properties due to sustained release of fluoride. GICs have 
coefficient of thermal expansion similar to that of the tooth structure which results in proper 
thermal compatibility with tooth enamel and dentin expansion [9]. Other advantages of GICs 
include low cytotoxicity and proper biocompatibility with the oral environment, minimized 
shrinkage after setting reaction, and reasonable aesthetics [15].  
Disadvantages of the GICs, on the other hand, include relatively prolonged setting reactions, 
low wear resistance, sensitivity to water uptake, and more importantly, low compressive and 
tensile strength particularly at the early stages of placement (first 24 h). They cannot be subjected 
to excessive masticatory load unless they are sufficiently supported by surrounding tooth structure. 
Their weak mechanical strengths compared to dental composite resins and amalgam have excluded 
the GICs as the first choice of restorative material for multi surface restorations (e.g. Class I and 
II cavities), especially posterior restoration [9]. 
 
 
1 Surgical dressing used to protect the wound created by periodontal therapy. 
7 
 
2.2.1 Physicochemical nature of GICs 
GICs, in essence, are composite materials composed of a cross-linked polyacid matrix in 
which the glass particles are dispersed [16]. The generic name of glass ionomers is rooted in the 
original components being the fluoroaluminosilicate glass and the polyacrylic acid. The GIC is the 
outcome of an acid-base reaction between the ion leachable fluoroaluminosilicate glass and the 
polyacrylic acid homo and copolymers. The GIC glass component is a finely ground powder with 
ability to react with acid which serves as a source of ions for the cement forming reaction. 
Conventionally, the main components of GIC glass powder are SiO2, Al2O3, CaF2 (as the flux) and 
commonly NaF, Na3AlF6 and AlPO4. The data points indicated in the ternary diagram of SiO2 – 
Al2O3 – CaF2 (Fig. 2.1) represent the experimental glass compositions investigated by Wilson et 
al. [17].  
 
Fig. 2. 1. The data points representing the experimental fluoroaluminosilicate glass compositions 
from Wilson et al. [17]. 
Originally, the reason behind including the fluorine in the glass structure was it to serve as 
a network disrupter (i.e. network modifier) facilitating the ion release required for setting reaction. 
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However, the anticariogenic effect imparted by fluoride release from the glass particles was 
clinically proven at the early stages of development of GICs [1, 9, 10]. 
To synthetize the GIC glass powder, components are well mixed then melted at elevated 
temperatures (1100-1500 ℃ depending upon the glass chemical composition). The molten mixture 
then is quenched down to room temperature and ground into fine powder. Silica and alumina form 
the backbone of glass structure while phosphate and fluoride ions modify the setting characteristics 
of the GIC [14]. 
 The other major component of the glass ionomer cements is the liquid (i.e. polyacid) which 
is a polymeric acid with carboxylic groups. In order to avoid gelation, the molecular weight of the 
acid should be low [1]. In the formulation of the earliest experimental GICs, an acrylic acid 
homopolymer solution (50 wt%) was used as liquid element [18]. The chemical structure of acrylic 
acid is shown in Fig. 2.2 The liquid component of the GIC will be discussed in further details later 
in this chapter.  
 
Fig. 2. 2. Chemical structure acrylic acid monomer [14]. 
GICs are divided to two major categories: conventional, and resin-modified. Both conventional 
and resin-modified GICs (RG-GICs) are considered conservative materials as they require 
relatively minimal cavity preparations allowing more natural tooth material to be retained [19]. 
The main difference is that the RG-GICs contain a polymerizable monomer, 2-hydroxyethyl 
methacrylate (HEMA), as an additional component along with the polyacid. They also contain 
suitable initiators to cause the HEMA to polymerize. Typically, these polymerization initiators are 
light-activated thereby the commercially available RM-GICs are mostly light curable. Originally 
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introduced as a liner/base material, RM-GICs are known to have similar mechanical properties to 
those of conventional GICs [19]. They have typically been the material of choice where aesthetics 
is important. However, RM-GICs have inferior biocompatibility compared to conventional GICs 
mainly for two reasons: Firstly, due to HEMA content, free monomers can be released from the 
set cement [20]. HEMA has been shown to exhibit cytotoxicity when in contact with the dental 
pulp tissue and osteoblasts by inhibiting cell proliferation [21]. Secondly, RM-GIC undergo an 
excessively high setting exotherm which can be harmful to the surrounding soft tissues [22].  
Due to their extensive variations, nowadays GICs are regarded as a ‘group’ of materials [1]. 
They are classified in three different types depending on their applications: Luting and bonding 
materials, restorative materials, and liner or base cements [1]. Luting and bonding GICs are used 
to hold indirect restorations such as bridges, crowns and orthodontic brackets in place [9]. 
Restoratives GICs are radiopaque materials with higher compressive strength and wear resistance 
compared to those of other types owing to their higher powder/liquid ratio (P:L) [9, 19]. Liner/base 
cements are typically used as a thin layer underneath the restoration to act as either a thermal 
insulator or dentin replacement [9, 19]. All three types of GICs are delivered as either conventional 
or resin-modified materials [19].  
2.2.2 Setting reaction 
The setting reaction in GICs is greatly dependent on the composition of the glass powder 
and the liquid. In principle the hardening process of all GICs is rooted in the acid-base reaction 
characteristic of dental cements. Upon mixing, the polyacid liquid attacks the surface of the ion-
leachable glass particles. As a result of glass surface dissolution, metal ions such as aluminum, 
calcium and strontium are released. The released ions cross-link with polyacid to form a hydrogel 
matrix in which the glass particles are embedded [23]. A schematic illustration of setting reaction 




Fig. 2. 3. The setting mechanism of glass ionomer cements [24]. 
A completely set GIC can be described as a composite in which silica-gel-surrounded glass 
particles are uniformly dispersed in a matrix of polyanions cross-linked by ionic bonds [23, 24]. 
Fig. 2.4. presents a scheme of the structure of a fully set GIC. 
 
Fig. 2. 4. The structure of the fully set cement [24].  
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G-200 was the first glass composition (SiO2–Al2O3–AlF3–CaF2–NaF–AlPO4) capable of 
forming a clinically useable dental cement when mixed with a 50 % polyacrylic acid solution [3]. 
The composition of G-200 is presented in Table 2.1.  
Table 2. 1. Composition of the first GIC glass G-200 [1]. 







 The G-200 -derived cement which was the first practical GIC was reported to be an 
aluminosilicate polyacrylate (ASPA) cement [14]. It was named ASPA-I. Despite being clinically 
usable, there were concerns regarding the ASPA-I such as sluggish set and limited working time. 
It had also poor aesthetics which was attributed to the high fluoride content of G-200 resulting in 
the glass becoming densely opaque rather than translucent. To overcome these limitations, the role 
of a third component, a chelating agent, in the setting reaction was investigated. It was found that 
the addition of tartaric acid, as a reaction controlling additive, prolonged the working time [9]. The 
tartaric acid prevented the formation of calcium polyacrylate resulting in restriction of the initial 
set allowing the GIC to retain fluidity for a longer duration. It was also reported that tartaric acid 
accelerated the final setting by promoting the formation rate of aluminum polyacrylate. Shortening 
the setting time favorably reduced the cement exposure to the damaging effects of moisture during 
clinical placement [25]. Tartaric acid also enhanced the compressive strength and improved the 
resistance to acid dissolution of cement [26]. 
ASPA-II was the updated version of ASPA-I containing tartaric acid, polyacrylic acid and 
G-200 glass. It presented improved handling characteristics. The discovery of the effect of tartaric 
acid in GIC formulation opened the door for further investigations including the use of more 
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translucent glasses replacing the opal G-200 which resulted in subsequent versions of ASPA-II 
with favorable clinical characteristics [18].  
As mentioned earlier, tartaric acid was added to the liquid formulation in order to improve 
the handling properties. Despite positive effects, tartaric-acid-modified-GICs showed inadequate 
shelf time (limited to 10-30 weeks) restricting their potential for commercialization. Inadequate 
shelf time was attributed to the gelation caused by intermolecular hydrogen bond formation [3]. It 
was suggested that copolymers of acrylic acid with other unsaturated carboxylic acids such as 
itaconic acid and maleic acid, would increase the shelf life. This was due to the presence of two 
carboxyl groups in the copolymer structures which resulted in higher degree of crosslinking. 
Consequently, the intermolecular hydrogen bond formation was reduced providing adequate shelf 
time [27]. The development of copolymers of acrylic acid with itaconic acid or maleic acid has 
also been reported to enhance mechanical performance of GICs [3].  
The molecular weight and the concentration of polyacrylic acid have been reported to affect 
GIC properties [28]. At low concentrations of polyacrylic acid, due to further distance between 
polymer chains, crosslinking between the molecules during setting is inhibited which leads to 
reduced compressive strength and modulus of elasticity in GICs [29]. Higher polyacid 
concentration and molecular weight leads to increased crosslinking between polymer chains 
resulting in a progressive improvement in diametral tensile strength, compressive strength, 
modulus of elasticity, and three-point flexural strength [30]. It should be mentioned that there is 
limit to the concentration and molecular weight of the polyacrylic acid solution above which the 
viscosity of the liquid is excessively increased making the solution clinically unemployable [29]. 
Dynamic mechanical thermal analysis of GICs identifies these materials as thermoplastic 
polymer composites in which the ionic crosslinks are repeatedly breaking and reforming [31]. The 
fracture of GICs may be explained by the entanglement theory [32] where a polymer chain under 
stress is viewed as being contained within a tube which is formed by the neighboring chains (Fig. 
2.5). It has been reported that the longitudinal movement of the chain is confined by the 
interlinkages of polar side groups between neighboring chains whereas the chain lateral movement 
is restricted by the proximity of the neighboring chain entanglements. Since the movement of such 
polymer chain confined in a tube of entanglements is similar to that of a snake, the entanglement 




Fig. 2. 5. A schematic of a polymer chain restricted in a tube of 3D entanglements [33]. 
2.2.3 Role of water 
Water is an essential element in GIC structure. It acts as reaction agent during the hardening 
process. When the carboxylate groups are active and ready for ion transfer, the water provides the 
proper medium for ion movement [10]. When the cement is set, water hydrates the GIC which 
leads to stabilization of the cement and prevents desiccation. It also allows for ions such as fluoride 
to diffuse and inhibit secondary caries [34]. 
After setting, there are gradual changes in GICs that slowly continue for a significant time, 
at least a year [25]. These changes are generally described as maturation. For instance, a freshly 
set GIC shows a degree of plastic character. However, it becomes less plastic and progressively 
rigid over time as ionic crosslinking increases resulting in increase in compressive and diametral 
tensile strength [35]. These changes in mechanical properties is known to be attributed to increase 
of proportion of bound water within the GIC. Since GICs are based on water soluble polymers 
with no phase separation on hardening, their structure and setting characteristics are heavily 
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affected by the role of water within the set cement [16]. GICs contain water in two distinguishable 
states of “loosely bound” and “tightly bound”. This division is based on whether or not the water 
can be eliminated through either storage in a desiccator or by heating at 105 °C for an hour [18, 
24, 35]. It is known that the ratio of bound water increases as GIC matures which coincides with 
aforementioned increase in compressive and diametral tensile strength and decrease in plasticity 
[36]. It also has been shown that, translucency improves upon maturation [19].  
Newly placed GICs are capable of exchanging water with the surroundings. They gain 
water in humid conditions and lose water at low humidity. In a condition of 80 % relative humidity, 
GICs are found to be stable in terms of water gain or loss. Freshly prepared GICs are vulnerable 
to early contact with moisture as it causes swelling and dissolutions of ions into the saliva leading 
to destroyed aesthetics and roughened surface. Typically, a layer of varnish or petroleum jelly is 
applied immediately after GIC placement to protect it from water exchange. As the cement ages, 
GIC water sensitivity tends to decrease due to increase in proportion of bound water [37]. 
2.2.4 Fluoride release 
GICs ability to release fluoride is one of their main clinically advantageous characteristics. 
This feature allows them to potentially preclude and heal early carries attack [38]. Fluoride release 
is known to be an independent phenomenon in GICs which takes place in a sustainable fashion 
over at least five years after cement initial placement [39]. As a result of a study on long-term 
fluoride release of the GICs [40], the following equation was proposed to describe the releasing 
process:  
Total release = Bt + At1/2 
where A and B are experimental constants and t is time. The study showed that despite the long 
duration of the experiment (two and a half years), the GICs did not reach equilibrium which made 
it impossible to determine the diffusion coefficient. Nevertheless, it was confirmed that fluoride 
release consists of two stages. The first stage involved a quick short-term process called “early 
wash-out” which has a direct correlation with time. This high initial burst of fluoride occurred in 
the first 24 h of GIC placement. The amount of fluoride release was reported to be material 
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dependent. The second stage, on the other hand, involved a gradual and long diffusion-based 
process where fluoride release was proportional to the square root of time [41].  
It has been shown that the amount of fluoride release increases in an acidic environment 
[19, 9]. Lower pH promotes the erosion of the GIC matrix resulting in higher dissolution rates 
which maximizes the fluoride release into the surrounding environment. Interestingly, GICs are 
able to assist with controlling the demineralization around adjacent teeth and cavity margins 
through their own dissolution when exposed to acid attack [42, 43]. In a study [44], the effect of 
pH of the environment on fluoride release from various commercially available GICs including 
Vitremer (3M-ESPE), Fuji II LC (GC Corp), Ketak Nano (3M-ESPE) and Dyract Flow (Dentsply) 
up to 84 days after setting was investigated. It was shown that not only fluoride release increased 
in lower pH but also the fluoride release rate is material dependent (Fig. 2.6).  
     
           
Fig. 2. 6. Cumulative fluoride ion (F) release per specimen area (µg/cm2) from various 
commercial GICs: a) Vitremer, b) Fuji II LC, c) Ketak Nano and d) Dyract Flow [44].  
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GICs not only can release fluoride, but also can be “recharged” and act as a fluoride 
reservoir [45]. Their ability for refluoridation can be attributed to the presence of loosely bound 
water and the solutes in the porosities in GIC structure which enables the cement to exchange ions 
with an external medium (i.e. fluoridated agents) via passive diffusion [46]. Typically, 
refluoridation becomes more effective when the concentration of the fluoridated agent and 
frequency of fluoride application are increased [45]. Also, when refluoridated, GICs have been 
reported to have much better potential for fluoride re-release compared to that of other dental 
restoratives e.g. compomers and composites [47].  
2.2.5 Adhesion to the tooth surface 
The tooth structure (Fig. 2.7) consists of two types of tissue, enamel and dentin. Their 
compositions are presented in Table 2.2. As shown in Table 2.2, dentin consists of more water and 
less mineral phase compared to enamel making it more challenging to bond for dental adhesives 
[19]. There are fluid-filled tubules in dentin structure which may discharge moisture and 
compromise the bonding. Owing to their hydrophilic nature, both conventional and resin modified 
GICs can properly wet the surface of freshly cut dentin and form a reliable adhesive bond [9].  
 
Table 2. 2. Composition of enamel and dentin [48]. 
 Enamel Dentin 
Mineral phase (hydroxyapatite) 97% 69% 
Organic phase (mainly collagen) 1% 20% 





Fig. 2. 7. Structure of a typical incisor tooth [48]. 
The adhesion develops quickly where about 80% of the final bond strength is achieved in 
the first 15 min of placement followed by a gradual increase for several days [49]. The adhesion 
mechanism starts when newly mixed GIC paste wets the tooth surface. The free carboxyl groups 
in the GIC form hydrogen bonds to the layer of tightly bound water on the surface of the mineral 
phase of the tooth (i.e. hydroxyapatite). These hydrogen bonds which are the main cause of rapid 
development of adhesion in GICs, are gradually replaced by genuine ionic bonds formed from the 
released cations from the carboxylate functional groups of the GIC and the hydroxyapatite surface 
[1]. A schematic illustration of this mechanism is shown in Fig. 2.8. Subsequently, this process 
leads to slow formation of an interfacial ion-exchange layer between the carboxylate groups of the 
polyacrylic acid and the tooth surface [19, 50]. This interfacial ion-exchange layer has been called 




Fig. 2. 8. A proposed mechanism for adhesion of GICs to hydroxyapatite [50]. 
 
Fig. 2. 9. The interaction zone formed between tooth surface and GIC [50]. 
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In addition to formation of true chemical bonds which was described earlier, mechanical 
interlocking also has been shown to contribute to the adhesion of GICs to the tooth [19]. 
Mechanical interlocking is caused by two phenomena: (1) the formation of short cement tags 
within the surface of the dentin and (2) the development of a thin hybrid layer between collagen 
fibrils which are coated in hydroxyapatite, at the interface of freshly cut tooth surface and the 
newly placed GIC [19].   
2.2.6 Reinforcement methods 
Before discussing the reinforcement methods, it is worth mentioning that the clinical grade 
GIC must meet the minimum requirements described in the corresponding ISO standard 
(ISO9917-1: dental water-based cements; 2003) [51] which is selectively presented in Table 2.3.  
Table 2. 3. ISO requirements for physical properties of clinical grade GICs [51]. 
Property Luting cement Restorative cement 
Setting time (min) 2.5-8 2-6 
Compressive strength (MPa) 70 (minimum) 100 (minimum) 
Opacity, C0.70 - 0.35-0.90 
 
Since ASPA was introduced to the dental market in early 1970s, GICs have been constantly 
subjected to modification in order to overcome their limitations. To enhance the mechanical 
properties of GICs and enable their clinical use in posterior regions, various attempts have been 
made including the reinforcement of the GIC matrix by the incorporation of different types of 






Sced et al. [3] studied the effect of incorporation of carbon and alumina fibers to a 
commercial GIC (Chembond, Dentsply DeTrey) on flexural strength of the cement. The fibers 
were >1000 mm in length and ranged from 10 to 20 mm in diameter. They reported that 
incorporation of 25 vol% of carbon and alumina fibers into the GIC powder component resulted 
in an increase in flexural strength form 10 MPa to 53 MPa and 44 MPa, respectively. In another 
study, Kobayashi et al. [52] investigated the addition of short glass fibers of CaO–P2O5–SiO2–
Al2O3 (with varying lengths of 33.5–100.4 mm and diameters of 9.7–21.5 mm) to a commercially 
available hand-mixed GIC (HY Bond Glasionomer CX; Shofu Inc.). Glass fibers were added to 
the GIC powder component from 0 to 100 wt% and the resulting mixture was hand-mixed with 
the associated GIC liquid. Following 24 h water storage, the diametral tensile strength (DTS) of 
the prepared cements (60 wt% short glass fiber incorporation) increased from 11 MPa to 18 MPa. 
The three-point flexural strength (TFS) value was also enhanced from 8 MPa to 35 MPa (60 wt% 
short glass fiber incorporation). Addition of > 60 wt% short glass fiber led to major deteriorations 
of DTS and TFS values compared to those of the commercial GIC [3]. 
2.2.6.2 Metallic powder 
Simmons et al. [53, 54] studied the incorporation of amalgam alloy powder (Lumi Alloy, 
GC Corporation) to the glass component of commercially available GIC of Fuji II (GC 
Corporation). The GIC that resulted from this study (spherical amalgam alloy powder ratios from 
5:1 to 8:1 g:g) was later marketed by GC Corporation as Miracle Mix [54]. The compressive 
strength of the Miracle Mix (104 ± 7 MPa) were reported to be significantly higher than that of 
Fuji II (65 ± 4 MPa) after 1 h of storage in water [55]. However, due to the poor interfacial bonding 
between amalgam powder and GIC matrix, the reinforcing effect of the amalgam alloy to GIC was 
reported to be limited [56]. 
In another study [57], Fuji II was reinforced with acid-etched stainless-steel powder (mean 
= 9 µm) and the resulting cements were compared to Miracle Mix. Compressive strength (268 ± 
15 MPa) and DTS (23 ± 2 MPa) values of experimental stainless-steel reinforced cements (17 
vol% addition) was reported to be higher than those obtained from Miracle Mix (169 ± 10 MPa 
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and 11 ± 2 MPa, respectively). Despite improving the mechanical performance, metal reinforced 
GICs were not tooth-colored and showed poor biocompatibility [56].  
2.2.6.3 Hydroxyapatite 
As shown in Table 2.2, hydroxyapatite (HA) is the main constituent of tooth structure [3]. 
The incorporation of HA into two experimental GIC glasses G-200D (16.6 wt% Al2O3, 29.0 wt% 
SiO2, 5.0 wt% NaAlF6, 34.3 wt% CaF2, 5.3 wt% AlF3, 9.9 wt% AlPO4) and MP-4 (35.0 wt% 
Al2O3, 28.0 wt% SiO2, 26.0 wt% CaO, 11.0 wt% Na2O) was studied [58]. In both cases, it was 
reported that increasing the HA content in GIC powder component, negatively affected the 
compressive strength of the resulting cements following 24 h water storage. Compressive strength 
of G-200D derived GIC was reduced from 20 ± 1 MPa to 8 ± 1 MPa when the HA content was 
increased to 50 wt% while MP-4 derived GIC showed a decrease in compressive strength from 55 
± 8 MPa to 26 ± 2 MPa after incorporation of 25 wt% HA [58].  
The effects of addition of HA (5 wt%) nano powder with particle size ranged from 100 to 
200 nm to Fuji II on compressive strength, DTS, and biaxial flexural strength (BFS) was studied 
[59]. As a result, an extensive improvement in mechanical properties was reported where the 
compressive strength increased from 160 MPa to 177 MPa, the DTS increased from 12 MPa to 16 
MPa and the BFS increased from 14 MPa to 26 MPa in comparison to those of Fuji II control 
specimens [59]. 
2.2.6.4 Bioactive glass particles  
There has been a growing interest in improving the mechanical performance of GICs 
through incorporation of bioactive materials (e.g. bioactive glasses and bioactive glass-ceramics) 
[21, 58, 60, 61, 62, 63, 64] where GICs remineralizing capacity can also be benefited. Ca and PO4 
ions released from GICs containing bioactive particles can promote the HA formation leading to 
enhanced interfacial adhesion between the GIC and the tooth surface [61]. GICs with enhanced 
mechanical and remineralizing properties are of special interest since they can notably broaden 
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GICs potential applications [64]. Bioactive glasses and glass-ceramics will be further discussed in 
section 2.3.1.  
The effects of incorporation of S53P4 bioglass particles (Vivoxid Ltd.) in Fuji II was 
studied by Yli-Urpo et al. [65]. They reported that the compressive strength of the cements after 1 
d of storage dropped from 120 ± 20 MPa to 105 ± 30 MPa when 10 wt% bioactive glass was 
substituted in GIC powder component.   
Kim et al. [63] reported that incorporation of bioglass nanoparticles (85 mol% SiO2, 15 
mol% CaO) into conventional GICs increased their mechanical properties including compressive 
strength, DTS and flexural strength. Surface bioactivity (i.e. in vitro biomineralization) was also 
reported as a result of bioglass incorporation. In another study, Valanezhad et al. [21] reported that 
the incorporation of 3 wt% nanoparticles of a sol-gel derived bioactive glass (70 mol% SiO2, 30 
mol% CaO) resulted in increasing the flexural strength of the tested RM-GIC by up to 30%. 
2.2.7 Atraumatic Restorative Treatment (ART) 
It is known that dental caries are the most common noncommunicable disease in the globe 
[66]. In response to the unavailability of dental restorative care for underserved communities, a 
minimally invasive operative approach namely Atraumatic Restorative Treatment (ART) was 
developed in the 1980s. Utilizing only hand instruments and a high viscosity GIC, ART provides 
an affordable alternative to manage decayed teeth and prevent it from being extracted where 
essential resources for modern dental treatment (e.g. plumbed water and electricity) are in short 
supply [66, 67]. In ART procedure, firstly, markedly softened carious enamel and dentin are 
removed using hand instruments. Then, the resulting cavity as well as the associated pits and 
fissures are restored using a hand-mixed high viscosity GIC [68]. Lastly, the material is pushed 
into the cavity for a few seconds using an index finger. Owing to their instant durable adhesion as 
well as their remineralizing effect when in contact with the hard tissues, GICs are the main, if not 
only, material of choice for ART [9].  
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2.2.8 Aluminum-free glass ionomer cements 
Although Al serves as a key element in GIC setting reaction, there are concerns regarding the 
release of Al ions from the GIC matrix. Al ion has been recognized as a neurotoxin which acts in 
favor of cellular oxidation [69] and breaks cellular homeostasis apart [70]. It has been reported 
that up to 77 days following implantation of an aluminum-containing bone cement, Al can be 
traced in the brain, cerebral spinal fluid, urine and blood [71]. Also, the pathological process of 
many neurological disorders such as Parkinson’s disease are thought to be related to Al presence 
[72]. Due to the aforementioned concerns, there has been a growing tendency for development of 
Al-free glass ionomers in the field of orthopedics and dentistry [71]. Since Al plays a key role in 
physicochemical properties, removing it from the structure poses challenges in achieving a GIC 
that meets standard requirements. These challenges as well as a novel straight forward approach 
to tackle them are discussed in chapter 5. 
2.3 Bioactive materials 
In general, a bioactive material is a material that has been engineered to induce certain 
biological activity [73]. In a more particular sense, a bioactive material goes through specific 
surface reactions when implanted into the body or exposed to biological fluid which leads to 
formation of a hydroxyapatite-like layer through which it forms a firm bond with the host tissue 
[74]. To assess if a material is bioactive, typically, it is immersed in simulated body fluid (SBF) 
and formation of a hydroxyapatite-like layer on the surface can be an indication of material 
bioactivity [73].  
 Depending on the rate of bone regeneration induced by the bioactive materials, they are 
classified into Class A and Class B. Class A bioactive materials can bond with both hard and soft 
tissues. They are both osteoconductive and osteoproductive which leads to the rapid formation of 
hydroxyapatite followed by the mineralization process resulting in the formation of a mature hard 
tissue structure [75, 76]. On the other hand, Class B bioactive materials are only osteoconductive 
so they are unable to provide a proper environment to stimulate the few osteoprogenitor cells to 
start the cell-division cycle [77].  
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 The invention of the first bioactive glass (i.e. 45S5 Bioglass®) by Hench in 1969 launched 
the field of bioceramics1 resulting in development of many new materials and products [77]. 
Various types of ceramic materials have been reported to be bioactive. They can be categorized in 
three groups [78]: 1) calcium phosphates, 2) bioactive glasses and glass-ceramics 3) other 
bioactive ceramics. Calcium phosphates are briefly discussed in the following while bioactive 
glasses and glass ceramics will be reviewed in section 2.3.1. 
 Synthetic hydroxyapatite (HA; Ca5(PO4)3(OH)) and tricalcium phosphate (TCP; 
Ca3(PO4)2) are the most important bioactive calcium phosphates. Depending on the condition, TCP 
is stable in various polymorphs where the α- and β-TCP are the two main forms [79]. The type of 
calcium phosphates can be determined by the molar ratio of Ca/P in their structure using Table 
2.4. 





A great deal of research has been carried out on synthetic HA due to its similar chemical 
structure to the hard tissue. However, its Class B bioactivity along with its poor fracture toughness 
and low in vivo degradation rate, have restricted its applications [79, 78]. The β-TCP has better 
mechanical performance and higher dissolution rate in comparison to synthetic HA [78]. Here are 
the dissolution rates of calcium phosphates: Amorphous HA > α-TCP > β-TCP > Crystalline HA 
[80]. 
One of the notable modifications of bioactive glasses is apatite-wollastonite (A/W) glass-
ceramic [79]. This glass-ceramic which was first invented in Japan in 1982, consists of a glassy 
 
 
1 “Bioceramic” is a general term that covers glasses, ceramics and glass-ceramics which are used as implant 
materials [82]. 
Ca/P molar ratio Calcium phosphate type 
< 1.67 α- or β-TCP 
> 1.67 CaO + HA phase 
= 1.67 (2.15 in weight ratio) HA 
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matrix (17 wt% MgO, 24 wt% CaO, 59 wt% SiO2) that contains 34 wt% of oxyfluorapatite 
(Ca10(PO4)6(O,F)2) (50–100 nm) and 28 wt% wollastonite (CaO.SiO2). A/W glass-ceramics are 
used in load bearing implants owing to their good mechanical properties and proper bioactivity 
[79]. Table 2.5 summarizes various mechanical properties of dense HA, 45S5 Bioglass® and A/W 
glass-ceramic.  
Table 2. 5. Mechanical properties of dense HA and 45S5 Bioglass® [80]. 
2.3.1 Bioactive glasses and glass-ceramics 
Bioactive glasses and glass-ceramics are the only materials that are capable of forming a bond 
with both soft and hard tissues in vivo [77]. These materials can be made in a variety of 
compositions and forms including powders, fibers, bulk and porous monoliths which lead to their 
extensive range of applications [80, 81]. There are several types of bioactive glasses such as silicate 
glass (e.g. Bioglass®), phosphate-based glass and borate-based glass [82]. Phosphate and borate 
glasses have higher dissolution rates compared to that of silicate glass. Particularly, borate glass 
has delivered promising clinical results in healing of chronic wounds (e.g. diabetic ulcers) which 
would not heal via conventional treatment [83]. The ability of borate glasses to response to soft 
tissues is thought to be associated with their fast dissolution rate. In fact, both borate and phosphate 
glasses benefit from their very rapid solubility rather than bioactivity which is an area dominated 
by silicate glasses [83]. The focus of this section will be on silicate glasses made by conventional 












HA >400 ~40 ~100 ~1.0 
45S5  
Bioglass® 
~500 42 35 0.5-1 
(A/W) glass-
ceramic 
1080 215 118 2.0 
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The mechanism that leads to bonding between a bioactive glass (or glass-ceramic) and the host 
tissue is associated with initial glass dissolution followed by formation of a carbonated 
hydroxyapatite (CHA) layer on the glass surface. CHA is a biologically active phase which has a 
similar structure to hard tissues and is believed to interact with collagen fibrils and form a bond 
with the host tissue [80, 84]. 
Formation of the CHA layer after dissolution of the bioactive glass or glass-ceramic takes place 
through a mechanism similar to conventional glass corrosion. Dissolution byproducts alter the 
chemical composition as well as the pH of the environment leading to formation of surface sites 
suitable for CHA nucleation [85]. Although a full understanding of the mechanism is yet to be 
achieved, it has been proposed that the following five stages are involved in forming the CHA 
layer (i.e. bone bond) in bioactive glasses and glass-ceramics in vivo or in vitro [86]: 
I. Rapid exchange of modifier cations (Na+ and/or Ca2+) with H+ from the solution which 
results in formation of silanol bonds (Si−OH) on the bioglass surface: 
Si − O- Na+    +    H+    +    OH-    →    Si − OH+    +    Na+(aq)    +    OH- 
As a result, the pH of the environment increases leading to formation of a silica-rich 
region close to the bioglass surface. If there is any phosphate present in the 
composition, it is dissolved from the glass at this stage. 
II. OH- groups attack the silica glass network and break Si−O−Si bonds due to high local 
pH. Soluble silica is released to the solution in the form of Si(OH)4 which leaves more 
silanol groups (Si−OH) at the interface of the bioglass and the solution: 
Si − O – Si    +    H2O    →    Si − OH    +    OH − Si 
III. Condensation of silanol groups near the bioglass surface and formation of Si−O−Si 
bonds resulting in repolymerization of the silica-rich layer.  
IV. Diffusion of Ca2+ and PO43- groups to the surface via silica-rich layer leading to 
formation of an incipient amorphous CaO-P2O5 -rich film. 
V. Crystallization of the CaO-P2O5 -rich film to CHA on the surface of the bioglass 




Similar to other properties of glass, the dissolution rate and thereby formation rate of CHA can 
only be understood in light of understanding the atomic structure of glass. The glass network 
consists of silica tetrahedra which are joined together by −Si−O−Si− bridging oxygens. Silicon 
acts as a network former and develops the glass structure by covalent bonding [77]. On the other 
hand, network modifiers such as sodium and calcium disrupt the structure by forming non-bridging 
oxygens (e.g. Si – O- +Na). Glass modifiers bond ionically to the network [77, 87]. According to, 
NMR analysis, there are no P−O−Si bonds in glass structure and phosphorous is present in the 
glass network in an orthophosphate form with charge balanced with Na and/or Ca [88]. As a result, 
the P is somehow isolated from the glass network and diverts network modifiers such as Na and 
Ca from their role. That is the reason behind rapid dissolution of P from the glass when exposed 
to aqueous medium [89]. Also, it has been known that the presence of orthophosphate in a bioactive 
glass promotes glass-in-glass phase separation which is why melt-derived bioglasses having ≥ 6 
mol% phosphate mostly exhibit two glass transition temperatures (Tg) [90].  
Network connectivity, Nc, is defined as the mean number of bridging oxygens per Si atom [90]. 
High silica content leads to high Nc meaning more chemical and physical stability which reduces 
the dissolution rate of the glass and therefore its bioactivity. Increasing the network modifiers 
content results in lower connectivity through disrupting the silica network. Since network 
modifying cations such as Na and Ca charge-balance the orthophosphate, higher phosphate content 
is shown to increase network connectivity. It has been reported that glasses with Nc values higher 
than 2.6 are most probably not bioactive because their structure resists dissolution [82]. 
Fig. 2.10 illustrates the compositional diagram of all melt-derived silicate glasses in SiO2 – 
CaO – Na2O system with 6 wt% P2O5. In region D, which is the silica-poor side of the diagram, 
there is no glass formation because of insufficient amount of network formers. Region B, on the 
other hand, is rich in silica (> 60 wt%) yet the resulted glass is bio-inert due to high network 
connectivity and minimal dissolution rate [91]. Region A represents the compositional area of 
glasses (52 – 60 wt% SiO2), which are able to bond to the hard tissue in 2 – 4 weeks. The glasses 
with compositions in region S, where silica content is 42 – 52 wt%, demonstrate Class A 
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bioactivity which means they can bond to both soft and hard tissues. The highest bioactivity index1 
belongs to the glass compositions in the small region of E which includes 45S5 Bioglass® [77].      
 
 
Fig. 2. 10. Compositional diagram of melt-derived glasses in SiO2 – CaO – Na2O system 
containing 6 wt% P2O5 [77]. 
2.3.2 45S5 Bioglass® 
45S5 Bioglass® was discovered by Hench at the University of Florida in 1969 [79]. The idea 
of finding a material which could form a bond to human bone was implanted in his mind after a 
bus ride conversation with a colonel from US Army who just returned from the Vietnam war. The 
colonel asked him about the possibility of developing a material that could withstand the harsh 
environment of the human body. Back at the time, all available implants reportedly resulted in 
fibrous encapsulation when implanted. Hench focused on making a degradable glass in Na2O–
CaO–SiO2–P2O5 system, high in Ca content, and close to an eutectic in Na2O–CaO–SiO2 
equilibrium phase diagram. The resulting composition was 45 wt% SiO2, 24.5 wt% CaO, 24.5 
 
 
1 Proposed by Hench, bioactivity index (IB) is used to assess and compare the bioactivity of the materials. IB is defined 
as a 100 divided by the time required for more than 50% of the material’s surface bonds to the surrounding tissues 
(t50bb) [77]. 
Region Description  
A Bone bonding  
B Too low reactivity (non-bonding)  
C Too high reactivity (non-bonding)  
D No glass formation  
S 
Soft and hard (bone) tissue 
bonding  
E 
Bioactive glasses with the highest 
level of bioactivity (rapidly bond 
to bone)  
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wt% Na2O, and 6.0 wt% P2O5 which was later termed 45S5 Bioglass
®. “45S” represents 45 wt% 
SiO2, the main glass former in this composition, and 5 is the key Ca:P molar ratio. As mentioned 
before, 45S5 Bioglass® has the highest bioactivity index (IB=12.5) among the bioactive glass 
compositions (see Fig. 2.10) [77]. A selection of properties of melt-derived 45S5 Bioglass® are 
presented in Tables 2.5 and 2.6.  
Table 2. 6. Selected properties of melt-derived 45S5 Bioglass® [82]. 
 
45S5 Bioglass® particles with high specific surface area have been reported to have 
antibacterial effect. This effect is key in areas such as tissue repairing in dentistry where infected 
root canals are involved [92]. Rapid solubility of 45S5 Bioglass® nanoparticles results in sharp 
increase in pH of the surrounding aqueous environment, a condition cannot be tolerated by 
microbiota [93].  
2.3.2.1 Structure 
The network structure of the 45S5 Bioglass® is shown in Fig. 2.11. Si, as the main network 
former, covalently bonds to bridging oxygen atoms while the network modifiers, Na and Ca, are 
ionically bonded to the glass structure through broken oxygen bonds. The formation of ionic bonds 
between non-bridging oxygen atoms and modifiers is due to maintaining the electroneutrality [82, 
86]. The presence of network modifiers has various effects on the Bioglass® properties. They 
decrease chemical, physical and mechanical stability through disrupting the silica network. They 
also play a key role in the first step of formation of the CHA layer in vivo and in vitro as they are 
rapidly exchanged with H+ from the solution that results in formation of silanol bonds (Si−OH) 
on the Bioglass® surface. In fact, the high content of network modifiers in the composition (total 
Property Value 
Density 2.7 g/cm3 
Network connectivity 2.12 
Thermal expansion coefficient 15.1 × 10-6 ℃-1 
Elastic modulus 35 MPa 
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of 49 wt%) is one of the main reasons for outstanding bioactivity of the 45S5 Bioglass® because 
it makes the network easier to break down resulting in more rapid solubility rate [94].  
 
Fig. 2. 11. Network Structure of 45S5 Bioglass®. Note that Na and Ca ions are removed for 
clarity. NBO = non-bridging oxygen, BO = bridging oxygen [82]. 
Surprisingly, despite the great deal of research carried out on bioactive glasses over the past 
almost 50 years, no other bioglass composition has been known to have better biological 
characteristics than 45S5 Bioglass® composition [82].  
2.3.2.2 Thermal behavior 
 Thermal behavior of 45S5 Bioglass® has been thoroughly researched in the literature [95, 
96, 97] and it will be discussed in detail in chapter 3. In brief, following the glass transition at Tg1 
= 550 ℃, 45S5 Bioglass® undergoes a glass-in-glass phase separation at 580 ℃ resulting in 
formation of two glassy phases: a silicate-rich phase and a phosphate-rich phase. Higher silica 
content results in high viscosity in the silica-rich phase thereby the flow behavior is dominated by 
this phase [96]. The formation of the phosphate-rich domains is known to have a catalytic effect 
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on crystallization of the silica-rich phase. They act as nucleation sites and reduce the required 
energy for nucleation of the silicate-rich nuclei. Combeite (Na2Ca2Si3O9), which is known to be a 
mechanically strong phase due to high silica content, crystallizes from the silica-rich glassy phase 
between 610 to 700 ℃ whereas silico-rhenanite (Na2Ca4(PO4)2SiO4)) evolved from the phosphate-
rich phase at 800 ℃. It should be noted that the phosphate-rich phase is still present after combeite 
crystallization [95]. A second glass transition occurs at Tg2 = 850 ℃ and eventually, melting occurs 
in the range of 1070−1278 ℃ [96]. Fig. 2.12 demonstrates the 45S5 Bioglass® thermal phase 
transformations. 
 
Fig. 2. 12. 45S5 Bioglass® structural transformations [96]. 
2.3.2.3 45S5 Bioglass®-ceramic 
A major shortcoming that restricts the application of bioactive glasses as implants in load-
bearing areas is their low mechanical properties [96]. Transformation of bioactive glasses to glass-
ceramics through heat treatment is one of the practical techniques to improve their mechanical 
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properties. Although crystallization of bioactive glasses leads to diminishing or sometimes 
neutralizing their bioactivity [98], it has been reported that the bioactivity is maintained in 
crystalline 45S5 [99]. Filho et al. [100] studied the effect of crystallization of 45S5 Bioglass® on 
CHA layer formation in vitro. It was shown that after 20 h exposure to SBF, the glass-ceramics 
with < 60% crystallinity were able to form a crystalline CHA layer whereas the glass-ceramics 
with more than 60% crystallinity developed only an amorphous calcium phosphate within the same 
time period. Interestingly, increasing the SBF exposure time to 40 h resulted in fully development 
of a crystalline CHA layer on the surface of glass-ceramics containing > 60%. It was concluded 
that crystallization of 45S5 Bioglass® did not compromise its bioactivity and 45S5 glass-ceramics 
with crystallinity ranged from 8 to 100% remain bioactive in vitro, however, the onset time of 
CHA layer formation was reported to increase from 10 h for amorphous Bioglass® up to 22-25 h 
for the material with 60-100% crystallinity (Fig. 2.13). Also, the rate of CHA layer formation of 
45S5 glass-ceramics was found to be up to seven times higher than that reported of A/W glass-
ceramics [99, 100]  
 
 
Fig. 2. 13. Effect of percent crystallization of the 45S5 glass-ceramic on the onset time of CHA 
formation (stage 5) [100]. 
Degree of crystallinity (%) 
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The mechanical properties of an amorphous material are known to increase as it crystallizes 
thereby, transforming the 45S5 Bioglass® to Bioglass®-ceramic through controlled heat treatment 
is a practical approach to enhance their performance [80]. Consequently, along with outstanding 
remineralizing properties (i.e. bioactivity), improved mechanical performance can also be 
exploited from 45S5 Bioglass®-ceramics. This in fact was the underlying idea behind the approach 
chosen in this research work in developing glass ionomer cements with improved mechanical and 
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Abstract. Combeite (Na2Ca2Si3O9) is a mechanically strong phase that crystallizes from 45S5 
Bioglass® during heat treatments. 45S5 glass-ceramics are expected to not only retain desirable 
levels of bioactivity but also exhibit improved mechanical properties compared to those of the 
amorphous 45S5 Bioglass®. However, producing crystalline 45S5 glass-ceramics containing 
solely combeite is challenging since other phase(s) may also form during the heat treatment 
process. In this study, we developed a comprehensive set of heat treatment regimes that can be 
used to control the formation of combeite in order to tailor the crystallinity of 45S5 glass-ceramics 
over a wide range of 5% to 95%. These heat treatments were designed based on controlling the 
nucleation and growth temperatures and times of the combeite phase, also preventing other 
potential phases from forming. Correspondingly, the activation energy for crystallization of 
combeite was calculated based on three different analytical methods and then used to obtain the 
Avrami exponent of the Bioglass® powder (n = 0.71). The results indicated that the crystallization 
of combeite occurred mainly on the surface of the particles.  
Depending on the target application, different levels of mechanical properties and 
bioactivity in bioglasses may be required. The crystallinity of 45S5 Bioglass® can be adjusted by 
applying the appropriate heat treatment regime selected from the profiles developed in this study.  
   




1 This Chapter is published as: A. Zandi Karimi, E. Rezabeigi, and R. A. L. Drew, “Crystallization behavior of 




45S5 Bioglass®, 45% SiO2, 24.5% CaO, 24.5% Na2O and 6% P2O5 (wt.%), is the first 
bioactive material reported in 1969 by Hench [84]. This bioglass which is approved by the US 
Food and Drug Administration (FDA) has been extensively studied due to its Class A bioactivity 
and successful clinical history [86, 101-103]. Class A bioactive glasses 
are osteoconductive and osteoproductive and exhibit the highest rate of hydroxyapatite (HA) 
formation (i.e. mineralization) in vitro and in vivo which are essential for tissue engineering 
applications [104]. However, there is still a great deal of ongoing research carried out on this 
bioglass as an additive to other biomaterials such as bioactive composite scaffolds [105] and dental 
restoratives (i.e. glass ionomer cements (GICs) [61]. The 45S5 bioactive glass is one of the main 
compositions that is currently being investigated for the next generation of biomaterials designed 
to prevent tissue loss which shows the importance and tremendous potential of this bioglass [106, 
107].  
In general, increasing crystallinity of a glass structure enhances its mechanical properties 
[96]. For example, apatite/wollastonite (A/W) glass ceramics are widely used not only for their 
bioactivity, but also their relatively high mechanical properties including compressive strength, 
tensile strength and fracture toughness [108]. The application of 45S5 as an additive or a load-
bearing implant is limited due to its overall low mechanical properties, in particular fracture 
toughness [108]. Alternatively, mechanical properties of this bioglass can be improved via 
controlled heat treatments allowing for the formation of crystalline phases with higher strength 
such as the silica-rich combeite phase which will be further discussed below [98, 99]. An 
appropriate heat treatment can also cause reduction in thermal stresses produced during shock 
cooling of the glass [109]. Although the bioactivity level of most bioactive glasses is drastically 
diminished upon crystallization, it has been shown that 45S5 glass-ceramic containing combeite 
(Na2Ca2Si3O9) crystals with a high degree of crystallinity, even up to 100%, can maintain its 
bioactivity [100]. The high bioactivity of 45S5 composition is mainly attributed to the relatively 
large amount of specific glass modifiers, sodium and calcium, in its structure, making it easier to 
dissolve in vitro and in vivo [111-113].  
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During heating scans, the first glass transition of 45S5 composition occurs at 550℃, 
followed by a spinodal transformation of the glassy phase into two immiscible phases at 580℃ 
[96]. This glass-in-glass phase separation is due to the coexistence of Si4+ and P5+ in glass structure 
as both of these ions have high valence numbers and each ion type prefers to concentrate separately 
[115, 116]. As a result, one of the phases is rich in phosphorus (P-rich) and the other phase is rich 
in silicon (Si-rich) of which the latter forms an important crystalline phase known as combeite 
(Na2Ca2Si3O9). Most studies [106, 117–120] have reported the formation of combeite as the 
dominant crystalline phase as a result of heat treatment of the Bioglass® above 600℃. Further 
increase in the temperature, up to 800℃, may also result in the formation of a P-rich crystalline 
phase known as silicorhenanite (Na2Ca4(PO4)2SiO4) [96].  
There has been always a dilemma associated with synthetic biomaterials: biomaterials 
which are mechanically stiff tend to be bioinert, whereas degradable biomaterials are normally 
relatively fragile. Chen et al. [98, 99] showed that combeite is a mechanically strong phase which 
can improve the overall stiffness of the bioactive 45S5 composition. Depending on the amount of 
combeite formed (i.e. the degree of crystallinity), bioactivity and stiffness of the Bioglass® can be 
tailored to suitable levels according to the requirements of target applications such as bone 
scaffolds and GICs [105, 121]. However, obtaining 45S5 glass-ceramic containing only combeite 
is challenging due to the possibility of the formation of a secondary crystalline phase during the 
heat treatment of 45S5 Bioglass® [96, 97].  
The main focus of this study is to develop four controlled heat treatment profiles which 
can be used to tailor the crystallinity of 45S5 Bioglass® within a wide range of 5% to 100% via 
the formation of combeite as the only crystalline phase in the resulting glass-ceramic structures. 
We designed three of these heat treatment regimes (crystallinity from 5% to 95%) based on 
controlling the nucleation and growth temperatures and times of the combeite phase. The result of 
thermal analysis under various conditions are used to design these three heat treatment processes 
which are then verified by characterizing their resulting glass-ceramic products using various 
methods. The fourth regime adopted from the literature to achieve 100% crystallinity in the 45S5 
Bioglass® [100].  
37 
 
3.2 Materials and Methods 
3.2.1 Materials 
The 45S5 Bioglass® used in this study was kindly donated by Dr. Robert Hill from Queen 
Mary University of London. The Bioglass® was produced via a melting-quenching process 
described elsewhere [119]. Briefly, all reactants were mixed and melted in a platinum/rhodium 
crucible at 1380 ℃ for 1 hour in an electric furnace followed by quenching in deionized water. 
After drying and re-melting the frit for 30 min., the resulting glass was ground using a vibratory 
mill (Gy-Ro mill, Glen Creston) for 7 min [119]. The as-received Bioglass® powder was analyzed 
by X-ray diffractometry (XRD) confirming its amorphous nature. Next, the glass powder was 
annealed at 460 °C for 8 h in order to remove any internal stresses that may be introduced during 
the grinding process [100]. Note that this temperature is below all phase transformation 
temperatures of 45S5 Bioglass® [97]. Hydrofluoric acid (Fisher Scientific) was used to prepare the 
etching solution. 
3.2.2 Heat treatment processes 
Four heat treatment profiles were carried out on the Bioglass® to obtain a wide range of 
combeite crystallization from 5% to 100% crystallinity. The heat treatment processes were 
performed under ambient atmosphere using a quartz tube furnace (model: GSL-1100X) and 
alumina crucibles. After the heat treatment cycles were finished, the furnace was shut down and 
the samples were allowed to cool inside the furnace down to room temperature. As presented in 
Table 3.1, three heat treatment profiles were designed and used to obtain crystallinity range from 






Table 3. 1. Heat treatment regimes designed in this study to induce various degrees of 
crystallinity in 45S5 Bioglass®. 
Heat treatment 
regimes 
Nucleation process Growth process 





620 ℃ 2 min. 
b 1 h 
c 3 h 
d 6 h 
e 12 h 
f 24 h 
Regime II 
a 
550 ℃ 6 h 
620 ℃ 
5 min. 
b 640 ℃ 
c 660 ℃ 
d 680 ℃ 
Regime III 
a 
550 ℃ 6 h 680 ℃ 
10 min. 
b 30 min. 
c 60 min. 
d 120 min. 




In order to achieve 100% crystallinity, the Bioglass® was nucleated at 550 °C for 150 h 
followed by another heating cycle up to 680 °C for 113 min to induce crystallization [100]. A 
heating rate of 10 °C/min was used in both cases. The resulting materials was then lightly ground 
in a pestle and mortar to eliminate the agglomerated particles produced during the heat treatment 
process. The as-received and heat-treated powders were stored in a desiccator for subsequent 
characterization. Each heat treatment profile was performed on five different Bioglass® samples. 
3.2.3 Characterization 
The as-received Bioglass® powder, after annealing at 460 °C for 8 h, was examined by 
XRD, to confirm that the resulting powder was fully amorphous. Laser scattering particle size 
distribution analysis (PSA; Horiba LA-920) was used to measure the mean particle size and the 
particle size distribution of this powder. Isopropyl alcohol was used as the dispersant.  
The heat treated Bioglass® powders were characterized by XRD (X'Pert Pro, PANalytical) 
using Cu Kα radiation to identify the amorphous structures as well as the degree of crystallinity. 
The 2θ values were collected in the range of 20 to 120°, however only those parts of the pattern 
containing useful information are reported here (15° < 2θ < 65°). X'Pert HighScore Plus Rietveld 
analysis software [124] was used to analyze the XRD patterns. The crystal size is also estimated 
based on the XRD results using the Scherrer equation. 
The thermal behavior of the Bioglass® and the glass-ceramics was also examined by 
differential scanning calorimetry (DSC; Setaram, Setsys 12) using 30 mg of powder and alumina 
crucibles. The DSC tests were conducted under nitrogen atmosphere at heating rates of 5, 7, 10, 
15, and 20 ℃/min. Also, the enthalpy of crystallization (ΔH) was computed using SETSOFT 2000. 
The grain structure of the heat-treated particles was observed using a 3D optical 
microscope (VHX-5000). Samples were examined further by scanning electron microscopy (SEM; 
HITACHI, S-3400N) equipped with energy-dispersive X-ray spectroscopy (EDS; Oxford 
Instruments; Wave Model). Prior to the SEM/EDS examination, the powder samples were lightly 
ground, cold mounted, polished, and etched with 0.02% HF solution for 20 s. Variable pressure 
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mode was used for imaging with probe current, accelerating voltage and emission current set to 60 
μA, 15 kV and 78 μA, respectively.  
3.3 Results and discussion 
Note that, based on the results of the particle size analysis, the mean particle size of the 
Bioglass® powder before the heat treatments was 4.6 µm wherein 60% of the particles were in the 
range of 0.5 to 15 µm.  
3.3.1 Thermal analysis  
The DSC results for the Bioglass® powder obtained at five heating rates are shown in Fig. 
3.1. Each DSC curve shows an endothermic peak corresponding to the glass transition temperature 
(Tg), followed by an exothermic peak corresponding to the crystallization process with the onset 
temperature of Tc and crystallization peak temperature of Tp [106]. Note that increasing the heating 
rate shifts the glass transition and crystallization peaks to higher temperatures and also makes them 
more pronounced [109]; whereas it does not affect the Tc [120]. Higher heating rates provide atoms 
with less time to diffuse and rearrange, thus obtaining thermal equilibrium is delayed causing all 
phase transformations including glass transition and crystallization to occur at higher temperatures 
[121, 125]. All the characteristics temperatures as well as the enthalpy of crystallization (ΔH) 
obtained from these curves are presented in Table 3.2. The enthalpy of crystallization (ΔH) is the 
area under the crystallization peak on the curve of heat flow versus time [126]. The ΔH values 
calculated for our systems are very close (mean =153 ± 4 J/g) and independent of heating rate 




Fig. 3. 1. The results of DSC analyses on the Bioglass® powder (before heat treatment) at various 
heating rates of a) 5, b) 7, c) 10, d) 15, and e) 20 ℃/min.  
Table 3. 2. Characteristic temperatures obtained from the DSC graphs in Fig. 3.1. 
Rate (℃/min.) Tg (℃) Tc (℃) Tp (℃) ΔH (J/g) 
5 539 620 694 149 
7 545 621 704 156 
10 549 622 706 153 
15 553 625 714 159 
20 556 626 725 150 
 
Fig. 3.2 shows the results of the XRD analysis on the Bioglass® after heat treatment at 
various temperatures. No peak is observed in the pattern of the Bioglass® heat treated at 600 ℃, 
whereas crystallization occurred by increasing the heat treatment temperature to 650 ℃, which is 
consistent with the results obtained from the DSC analyses (Fig. 3.1). The crystallized phase 
formed in the Bioglass® heated at 650 ℃ and above is combeite. Also, according to Fig. 3.1a and 
Table 3.2, the onset of crystallization in our bioglass is around 620 ℃ which is consistent with the 
crystallization temperature of combeite reported in other works [96, 106, 107].  
























Fig. 3. 2. XRD patterns of the 45S5 Bioglass® heat treated up to various temperatures a) 600, b) 
650, c) 700, d) 750, and e) 800℃. The corresponding DSC curve obtained at rate of 5℃/min. 
(Fig. 3.1a) is also presented. 
The XRD patterns containing crystalline peaks (Fig. 3.2 b, c, d and e) were used to obtain 
the crystallite size of combeite at various heat treatment temperatures using the Scherrer equation 
[122] applied to peaks with the highest intensity (2θ ≈ 34°) 
 
𝛽 =  
𝑘 .  𝜆
𝜍 . 𝑐𝑜𝑠 𝜃
                            equation (1) 
 
where β is the width of the peak at half maximum (in radian), ς is the size of the crystallite (in 
meters), k is the Scherrer constant (0.89) and λ is the wavelength of the incident X-ray (1.5406 × 
10-10 m). 
The crystal size of combeite calculated using Eq. (1) and the XRD patterns of Fig. 3.2 are 
summarized in Table 3.3. The results show that the size of the combeite crystals increases up to 
27 nm by increasing the heat treatment temperature from 650 ℃ and 800 ℃ [96]. 
 



















































Table 3. 3. Combeite crystallite size in the heat treated Bioglass® calculated based on the XRD 
results using Eq. (1). 
Heat treatment 
Temperature (℃) 
650 700 750 800 
Crystal size (nm) 21 17 15 27 
 
The results obtained from the DSC curves, including the characteristic temperatures of the 
Bioglass® (Table 3.2), were used to design the heat treatments in section 3.1.1. The DSC results 
can be also used to calculate the activation energy for crystallization which is an important kinetic 
parameter indicating the thermal stability of the amorphous phases. In other words, it can 
quantitatively anticipate the phase transformation behavior during the heat treatment of the 
Bioglass® [126]. 
Here, we calculate the activation energy for crystallization (E) of our bioglass based on 
three methods using the information obtained from the DSC curve of 5 ℃/min. (Fig. 3.2a). The 
Kissinger’s method [123] is one of the most common approaches to calculate E via a linear 
correlation between 1/Tp and (Tp






) =  
𝐸
𝑅𝑇𝑝
 + 𝐶                                                         equation (2) 
 
where V is the heating rate, C is a constant and R is the Boltzmann constant. 
Another approach to calculate the activation energy for crystallization is the Ozawa’s [124] 
which suggests E/R is the slope of ln(V) as a function of 1/Tp  (Eq. 3). 
  
ln 𝑉 =  
𝐸
𝑅𝑇𝑝
 + 𝐶                                                                     equation (3) 
 
Yinnon and Uhlmann [125] showed that E can be also determined by plotting ln(Tp/V) as 







) =  
𝐸
𝑅𝑇𝑝
 + 𝐶                                                          equation (4)  
Using the information from Table 3.1 and 2, Eqs. 2 to 4 were plotted as linear regression 
for the Bioglass® and the activation energy for crystallization (E) of combeite is calculated. In all 
three numerical approaches the slope of the resulting line was used to calculate the activation 
energy for crystallization. Thus, the linearity of the outcome shows the precision of the calculation. 
The R2 value for all three approaches is larger than 0.95. The three E values, 186, 198 and 192 
kJ/mol obtained from the Kissinger, Ozawa and Yinnon methods, respectively are in a good 
agreement. The average of these three values is considered as the activation energy for 
crystallization of combeite for our bioglass which is then used to calculate the Avrami exponent 
as explain in the following paragraphs.  
 
Fig. 3. 3. Kissinger  , Ozawa  , and Yinnon  plots for determining the activation energy for 























The mechanism of nucleation and growth of crystals can be defined by the Avrami 
exponent (n) which reveals whether the crystallization occurs mainly on the surface or within the 










                                                equation (5) 
 
where ΔT is the width of the crystallization peak at half maximum and E value is considered as 
192 kJ/mol as explained earlier. Thus, the Avrami exponent for our system is 0.71 which indicates 
that the crystallization of the combeite mainly occurs on the surface of the Bioglass® particles.  
3.3.1.1 Heat treatment design 
The process for designing our heat treatment regimes (Table 3.1) are explained as follows. 
A combination of three parameters, nucleation time, growth time and growth temperature, was 
used to obtain a wide range of crystallinity of combeite in the 45S5 Bioglass®. As explained before, 
the objective of this study was to have only combeite as a mechanically strong yet bioactive phase 
in the 45S5 glass-ceramics; thus, the nucleation temperature in all the heat treatment regimes was 
set at 550 ℃ which is the nucleation temperature of combeite [100]. In all heat treatment regimes, 
growth temperature ranged from 620 ℃, which is the onset crystallization temperature of combeite 
(Table 3.2 and Fig. 3.2), to 680 ℃ above which the P-rich crystalline phase formed. Note that, the 
Avrami exponent calculated for our system is less than one which indicates that combeite 
nucleation occurred by a surface crystallization mechanism. Dominant surface nucleation and 
growth may be caused by relatively large surface area of the Bioglass® particles [106].  
In order to obtain lower crystallinity values (up to 36%) in the Bioglass®, a short growth 
time of 2 min. was employed in heat treatment regime I (Table 3.2). Note that, various dwell times 
from 30 s to 5 min. were tested for the growth process of regime I, and 2 min. was selected as the 
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minimum time that delivered the results expected. Moreover, the lowest growth temperature for 
combeite, 620 ℃ [96], was used. The slow kinetic of combeite nucleation allows for maintaining 
the crystallinity within the low range of 5% to 36% using a wide range of nucleation times from 2 
min. to 24 h (Table 3.1) combined with 2 min. of growth time.  
The heat treatment regimes II and III were designed to achieve higher crystallinities (up to 
95%) which for the role of crystal growth can be more significant than that of the nucleation 
process. Thus, the growth temperature of these two regimes varied between 620 and 680 ℃ [96] 
whereas their nucleation temperature and time were kept constant at 550 ℃ and 6 h, respectively. 
In order to achieve higher amounts of combeite, the growth time of regime III (10 min. to 120 
min.) was increased in comparison with that of regime II (5 min.). The heat treatment regime IV 
was used to obtain a fully crystalline (100%) 45S5 containing only the combeite phase [100].  
In the next section these heat treatment regimes are assessed and validated through 
calculating the crystallinity of their resulting heat treated 45S5 Bioglass® using their XRD patterns.  
3.3.2 Degree of crystallinity 
In this section, XRD patterns of the Bioglass® powder which was heat treated according to 
various regimes (Table 3.1) are presented. These patterns were then used to calculate the degree 
of crystallinity of the heat treated material using Eq. 6 [128]: 
 𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝑐𝑟𝑦𝑠𝑡𝑎𝑙𝑙𝑖𝑛𝑖𝑡𝑦 =
𝐼𝑔− 𝐼𝑥
𝐼𝑔− 𝐼𝐵
 × 100                                      equation (6) 
where Ig is the noncrystalline scattering intensities measured at a single value of 2θ for the parent 
glass (zero crystallinity); Ix is the intensity for the partly crystallized glass; and IB is the intensity 
the crystalline compounds chemically equivalent to the parent glass. The angle (2θ) selected for 
this analysis must exhibit high noncrystalline scattering for the parent glass and is also free of 




Fig. 3. 4. XRD patterns of the 45S5 Bioglass® heat treated via regime I (Table 3.1): 
Crystallization of combeite after a) 2 min., b) 1h, c) 3h, d) 6h, e) 12h, and f) 24h nucleation time 
at 550 ℃ followed by growth at 620 ℃ for 2 min. Note that patterns a to f correspond to the heat 
treatments a to f of regime I in Table 3.1. 
The XRD patterns of the Bioglass® powder heat treated via regime I are presented in Fig. 
3.4. Note that all peaks in these patterns correspond to combeite. By increasing the nucleation time, 
the intensity of the main peak at 2θ ≈ 34° increased and a second peak gradually appeared. Using 
Eq. (6) the degree of crystallinity corresponding to these patterns (a to f) is 5, 10, 16, 21, 29 and 
36%, respectively.  
The XRD patterns of the Bioglass® heat treated via regime II are presented in Fig. 3.5 
showing more of the characteristic peaks of combeite with higher intensities compared to those of 
Fig. 3.4. As expected, the powders resulted from the heat treatment regime II have higher 
crystallinities (40, 57, 67 and 74%) than those produced via regime I.  




















Fig. 3. 5. XRD patterns of the 45S5 Bioglass® heat treated via regime II (Table 3.1): 
Crystallization of combeite after 6h nucleation time at 550 °C followed by 5 min. growth time at 
a) 620, b) 640, c) 660, and d) 680 °C. Note that patterns a to d correspond to the heat treatments 
a to d of regime II in Table 3.1. 
The XRD patterns of the Bioglass® powders heat treated regime III (Fig. 3.6 a to d) show 
that the crystallinity of these powders is respectively 84, 88, 91 and 95% which is higher than that 
of obtained from regime II (Fig. 3.5).  



















Fig. 3. 6. XRD patterns of the 45S5 Bioglass® heat treated via regime III and IV (Table 3.1): 
Crystallization of combeite after 6h nucleation time at 550 °C followed by a) 10, b) 30, c) 60, 
and d) 120 min. growth time at 680 °C. Note that patterns a to d correspond to the heat 
treatments a to d of regime III in Table 3.1. Pattern (e) which represents 100% crystallinity 
corresponds to the Bioglass® heat treated via regime IV.    
The 100% crystallinity is achieved using the heat treatment route proposed by Hench [100] 
which involves a nucleation at 550 °C for 150 h followed by crystallization and growth at 680 °C 
for 113 min.  
Fig. 3.7 summarizes the crystallinity of the 45S5 glass-ceramics heat treated via regime I, 
II, III and IV. As shown in this figure, a wide range of crystallinity can be developed using the 
heat treatment processes designed in this study which provides the opportunity of selecting the 
45S5 glass-ceramic with appropriate crystallinities for a particular target application.  
 




















Fig. 3. 7. Crystallinity of the 45S5 glass-ceramics heat treated via regime I  , II , III  and 
IV . The letters a to f on the X-axis correspond to those letters in Table 3.1 by which the heat 
treatments in each regime are denoted. 
3.3.3 Microstructures  
As an example, the microstructure of one of the heat-treated glass-ceramics with 74% 
crystallinity, obtained from regime II (Fig. 3.7), was examined and is discussed in this section. The 
micrographs of these glass-ceramic particles are presented in Fig. 3.8. The grain microstructure of 
the particles after etching was observed by optical microscopy and examined further by SEM.  
After nucleation of combeite phase, grains start to grow which eventually leads to Oswalt 
ripening wherein larger grains grow in expense of the smaller grains [96]. As a result of surface 
crystallization predicted by the Avrami exponent (n=0.71), the etched combeite grains observed 
on the surface of the particles (Fig. 3.8 b, d and e) were the result of partial dissolution of the 























































Fig. 3. 8. Optical microscopy images of the heat-treated glass-ceramic with 74% crystallinity 
before (a) and after (b) etching showing the transparency of the particles in both states. SEM 
images of the glass-ceramic particles before (c) and after (d and e) the etching. These SEM 
images were captured from larger particles to better show the grains and boundaries. Note that, 
the results of EDS analysis on a similar glass-ceramic sample are presented in Fig. 3.9. 
The two glass formers, Si and P [129], in 45S5 Bioglass® separate into two glassy phases, 
a Si-rich and a P-rich, at around 580 ℃ [96]. The higher viscosity of the Si-rich phase governs the 
flow behavior of the resulting phase separated system. As the temperature increases to 620 ℃, 
combeite crystallizes from the Si-rich phase at its interface with the P-rich phase. The high energy 
interface between these two glasses creates suitable nucleation sites for combeite crystallization 
[97]. The P-rich phase remained amorphous since silicorhenanite (Na2Ca4(PO4)2SiO4) only 
crystallizes at 800 ℃ [96, 97]. At these low temperatures, the combeite crystals continue to grow, 
while rejecting P and enriching the P-rich amorphous phase. This ultimately results in combeite 
crystallites surrounded by a P-rich glassy phase. This discussion is also confirmed by the 
compositional analysis performed on the etched samples (Fig. 3.9) as explained in the following.  
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Fig. 3. 9. a) SEM image of the etched Bioglass® with 74% crystallinity, along with 
corresponding X-ray map analysis for various elements: b) Ca, c) O, d) Na, e) Si, and f) P. 
The results of X-ray mapping analysis revealed two distinct elemental distribution patterns 
within and between the grains. Fig. 3.9 e and c, respectively, show high concentrations of Si and 
O within the grains indicating that these grains correspond to combeite (Na2CaSi3O9). On the other 
hand, considerable concentrations of Ca and P are observed between the grains (Fig. 3.9 b and f). 
Thus, the intergranular region between the combeite crystals is the P-rich amorphous phase which 
was preferentially dissolved during etching due to its lower chemical stability compare to 
combeite. This confirms that the combeite grains on the surface (Fig. 3.8) were surrounded by the 
P-rich phase prior to the etching as discussed above [113].  
3.4 Conclusion 
In this study, we introduced a comprehensive set of heat treatment regimes providing the 
possibility of tailoring the crystallinity of 45S5 Bioglass® between 5% and 95% by controlling the 
nucleation and growth of combeite as the only crystalline phase formed in this system. The heat 
treatment profiles were developed based on the results of DSC and XRD analyses on a melt-
a b c 




derived 45S5 Bioglass® powder. These results were also used to calculate the crystallization 
energy for and obtain the Avrami exponent of combeite which were then used to discuss its 
crystallization mechanism. It was shown that the combeite crystallization mostly occurred on the 
surface of the particles which was also confirmed by the SEM/EDS results. 
 45S5 glass-ceramics containing combeite as the sole crystalline phase are known to have 
improved mechanical properties while maintaining desirable levels of bioactivity. Such glass-
ceramics with appropriate degree of crystallinity for specific applications such as bone 
regeneration and additives for dental restoratives can be produced using the results presented in 
this study.  
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4 Chapter 4 
Glass ionomer cements with enhanced mechanical and 
remineralizing properties containing 45S5 Bioglass®-ceramic 
particles1 
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Montréal, Quebec H3G 1M8, Canada. 
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Abstract. The clinical applications of glass ionomer cements (GICs) are limited by their 
relatively poor mechanical properties and insufficient remineralizing capacity. In this study, we 
produced hybrid GICs with improved mechanical and remineralizing properties via incorporation 
of an optimum amount (5 wt%) of 45S5 Bioglass®-ceramic particles. Also, we found that 
Bioglass®-ceramic particles with 74% crystallinity best act as both remineralizing and reinforcing 
agents. The degree of crystallinity of the additives, is completely overlooked in this context in 
other research. At around 74% crystallinity, there is sufficient amounts of combeite and an 
amorphous phosphorous-rich phase in the 45S5 Bioglass®-ceramic particles to respectively 
promote their reinforcing role and simultaneously allow them to effectively partake in the setting 
process creating an excellent interfacial bond with the GIC matrix. As a result, several 
strengthening mechanisms such as crack deflection and crack-tip shielding are activated within the 
hybrid GIC containing 5 wt% Bioglass®-ceramic with 74% crystallinity, contributing to its 
improved mechanical properties. The enhanced remineralizing and mechanical properties of such 
hybrid GICs can potentially improve their in vivo performance and broaden their clinical 
applications.  
Keywords: Glass ionomer cements, Mechanical properties; 45S5 Bioglass®-ceramic; 
Remineralization; Crystallinity  
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Glass ionomer cements (GICs), first invented in 1972 by Wilson and Kent [130], are the family 
of biomaterials which are extensively used in clinical dentistry and bone replacement [19, 131]. 
GICs are the result of an acid-base reaction between an aqueous solution of polyalkenoic acid 
(either polyacrylic acid or acrylic/maleic acid copolymer) and an aluminosilicate glass powder 
[132]. The acid component attacks the glass particles resulting in the release of Ca2+ and Al3+ 
which then leads to the crosslinking of polymeric acid chains generating insoluble polysalts 
causing the cement to harden [133]. This hardening process gradually continues even after setting 
while the material becomes more translucent [19]. This post maturation process eventually leads 
to the formation of a silica gel layer around the glass particles during setting which detains further 
degradation [134].  
GICs are known for their good biocompatibility, lack of exothermic polymerization, ability to 
make direct chemical bonds to teeth or bones, negligible shrinkage upon setting and chemical and 
mechanical stability in aqueous environment [135, 136]. GICs release Ca2+ and PO4
3- in vivo which 
are the main constituents of hydroxyapatite (HA) that predominantly forms the inorganic portion 
of teeth and bones [19]. GICs also release F- in vivo which not only promotes the growth of dental 
hard tissues when applied in appropriate dosage, but also is a well-documented anticariogenic 
agent for teeth [137, 136]. This is due to the fact that F- forms fluorapatite (Ca₅(PO₄)₃F) via reacting 
with the hydroxyl group of HA. Fluoroapatite is thermodynamically more stable than HA and has 
higher resistance against plaque acid attack [133]. 
Despite all these advantages, GICs suffer from insufficient mechanical properties (e.g. strength 
and toughness) [138] limiting their permanent clinical use in load-bearing locations [138, 139]. 
Efforts have been made to overcome this limitation by modifying the chemical composition of the 
aluminosilicate glass [134, 140] or the polyalkenoic acid [141, 142] as well as other approaches 
including the incorporation of reinforcing agents into GICs such as glass fibers [139] or metallic 
oxide particles [140]. The incorporation of reinforcing particles can trigger various strengthening 
mechanisms in GICs such as crack deflection, crack branching, crack-tip shielding and particle 
pull-out [145, 146]. There is a growing interest to improve the long-term mechanical properties of 
GICs through incorporation of bioactive materials (e.g. bioactive glasses) [58, 60, 61] which can 
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also promote their remineralization capacity in atraumatic restorative treatment (ART) [141]. By 
promoting the formation of HA (mineralization) within GICs containing bioactive particles due to 
the release of Ca and PO4 ions, the interfacial adhesion between the cement and the native tissue(s) 
is improved via stronger chemical bonding. The development of GICs with enhanced mechanical 
and remineralizing properties can significantly improve their performance and broaden their 
potential applications.  
In the context of dental materials, it has been recently suggested to limit the term “bioactive” 
only to those materials that can lead to certain biomineralization within their clinical environment 
via the release of substantial amounts of ions [142]. According to this statement, GICs can be 
considered as bioactive, because they are able to leach ions through dissolution of calcium 
aluminosilicate glass particles which can potentially promote the interaction of GICs with the HA 
of dentin. However, their bioactivity can be improved and exploited by the incorporation of 
bioactive glasses. If the added bioactive glass converts to HA in a controlled fashion and time, the 
dental hard tissues underneath the restoration can benefit from the resulting interfacial 
biomineralization and adhesion [142]. The addition of various bioactive glasses with different 
particle sizes into GICs has resulted in different outcomes [21, 63, 65, 150]. Yli-Urpo et al. [143] 
reported that, the incorporation of commercially available bioactive glass S53P4 into a 
conventional GIC reduced the compressive strength of the cements on average by 54%, while they 
showed its antimicrobial effects on both S. mutans and C. albicans [144]. However, Kim et al. [63] 
showed that incorporation of bioglass nanoparticles (85 mol% SiO2, 15 mol% CaO) into GICs 
increased their mechanical properties including compressive, diametral tensile and flexural 
strength as well as in vitro biomineralization. Also, Valanezhad et al. [21] exhibited that the 
addition of 3 and 5 wt% nanoparticles of a sol-gel derived bioactive glass (70 mol% SiO2, 30 mol% 
CaO) enhanced flexural strength of their resin modified glass ionomer cements (RM-GIC) up to 
70% and 5%, respectively.    
45S5 Bioglass® (45 wt.% SiO2, 24.5 wt.% Na2O, 24.5 wt.% CaO, 6 wt.% P2O5), which was 
first invented by Hench in late 1960’s [95, 151], is known for its high bioactivity index [107] as 
well as its desirable antimicrobial properties [145]. However, Bioglass® that belongs to the most 
bioactive category of materials [146], normally exhibit inferior mechanical properties; thus, as an 
additive, it may diminish the compressive strength and microhardness of GICs [61]. 
Transformation of Bioglass® into a glass-ceramic through controlled thermal treatments, can 
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enhance its mechanical properties promoting its dual role as a remineralizing and reinforcing agent 
[95, 98, 100]. Heat treatments of 45S5 Bioglass® above 600 °C can result in formation of a 
mechanically strong phase named combeite (Na2Ca2Si3O9) [98]. Such glass-ceramics containing 
combeite maintain their bioactivity and potentially convert to HA in a controlled manner and time 
while exhibiting improved mechanical properties [148, 149].  
In this study, hybrid GICs containing various amounts of 45S5 Bioglass®-ceramic with 
crystallinities between 5% to 100% are developed; and the hybrid GICs leading to the best 
mechanical properties are identified. We show that, the incorporation of 5 wt% Bioglass®-ceramic 
particles with 74% crystallinity improves the mechanical properties of GICs by acting as 
reinforcing agent and simultaneously inducing mineralization within the cements.  
4.2 Materials and Methods 
4.2.1 Bioglass® synthesis and heat treatment 
The 45S5 Bioglass® used in this work was kindly donated by Dr. Robert Hill from Queen 
Mary University of London. The synthesis process of this Bioglass® was explained elsewhere 
[119]. In brief, high purity precursors in the form of powder were weighed and mixed according 
to the 45S5 Bioglass® formula. This powder mixture was melted in a platinum/rhodium crucible 
at 1380oC for 1 h using an electric furnace followed by quenching in deionized water. The frit was 
then dried and re-melted for 30 min. followed by grinding for 7 min. using a vibratory mill [119].  
The as-received Bioglass® powder was annealed for 8 h at 460 °C (mean particle size = 4.6 
µm) to remove any internal stress created during the grinding process [100]. Although, 460 °C is 
below all the phase transformation temperatures of 45S5 Bioglass® [95, 96], the amorphous nature 
of the powder was verified by X-ray diffraction (XRD).  
In this study, partially crystallized 45S5 Bioglass® (Bioglass®-ceramic) containing combeite 
was used. Four heat treatment profiles were used to obtain a wide range of crystallinities in the 
Bioglass® from 5% to 100% [95]. All the heat treatments were performed under atmosphere using 
a quartz tube furnace (GSL-1100X) and alumina crucibles. Note that these heat treatment profiles 
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are explained in detail in our previous study [95]. To eliminate the potential agglomerates produced 
during these heat treatments, the resulting powders were lightly ground in a pestle and mortar.  
4.2.2 Cement preparation  
The GIC capsules used in this study were obtained from ChemFil™ Rock Dentsply, Germany 
[147]. Each capsule contained a certain ratio of a calcium-aluminum-zinc-fluoro-phosphor-silicate 
glass powder to a liquid ionomer (polycarboxylic acid and tartaric acid) [147]. In order to 
incorporate our bioglass-ceramic into the GICs (i.e. to produce the hybrid GICs), the plunger was 
removed from the capsule and various portions of its original glass content were replaced (2, 5, 
10, 15 and 20 wt%) with our 45S5 Bioglass®-ceramic with 74% crystallinity. Note that, Bioglass®-
ceramic particles with 74% crystallinity can result in GICs with the highest mechanical properties, 
based on the results presented in section 3.1. Next, the two powders were mixed well using a 
Coulter mixer for 30 min. to reach homogeneity. The GIC capsule was then refilled with the 
resulting mixed powder and the plunger was reinserted. After activating the capsule, which 
initiated the reaction between the mixed powder and the ionomer liquid, it was immediately placed 
in a capsule mixer (HL-AH G5 Amalgamator) at 4000 rpm for 20 sec. The resulting material was 
then injected into cylindrical shaped silicone molds. Note that, all the samples were prepared at 
room temperature (21 ± 2 °C) throughout the whole process. Next, the cements were gently 
removed from the silicon molds and stored in an incubator at 37 ± 1 °C for 1 h. Subsequently, 
each cement was individually immersed in distilled water and stored again in the incubator at 37 
± 1 °C for 1 d or 7 d prior to the compression, diametral tensile and microhardness tests (n = 6). 
Note that, the samples were randomly allocated to test groups [148, 149].  
4.2.3 Mechanical testing 
A series of preliminary compression, diametral tensile and microhardness tests (n = 6) were 
carried out on the hybrid GIC specimens containing 5 wt% Bioglass®-ceramic with various 
crystallinities (5% to 100%) to determine the optimum degree of crystallinity that leads to the 
highest mechanical performance. Then, five groups of hybrid GICs containing 2, 5, 10, 15 and 
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20 wt% Bioglass®-ceramic with this optimum crystallinity (74%) as well as commercial GIC 
samples were analyzed for each mechanical test as described in the following sections.  
4.2.3.1 Compressive strength  
Compression tests were carried out according to ISO 9917-1 for powder/liquid acid based 
cements [51]. Cylindrical GIC specimens (D = 4 mm and h = 6 mm) were made by casting the 
final mixture into silicone molds. The tests were performed using an Instron 3382 Universal 
Testing Machine with a 5 kN load cell at a crosshead speed of 0.5 mm/min until failure occurred. 
The samples were placed with their flat sides in contact with the plates as shown in Fig. 4.1. The 




              eq (1) 
where CS is the compressive strength (MPa), P is the maximum applied load (N) and D is the 
diameter of the specimen (mm).  
  
 
Fig. 4. 1. Measuring the compressive strength of a GIC specimen before (a) and after (b) failure 
(the crack formed within the sample is indicated by the arrow).   
The fracture surface of the GICs after the compression test was examined using a scanning 
electron microscope (SEM; HITACHI, S-3400N) under high vacuum mode with the probe current, 






SEM, all specimens were coated with Au/Pd (70/30 wt %) using a rotary-pumped sputter coater 
(Quorum, Q150R ES). 
4.2.3.2 Diametral tensile strength (DTS)   
This is an alternative approach for testing brittle materials under tension without using grips. 
The diametral tensile samples were prepared (Fig. 4.2 a and b) in compliance with ISO 9917-1 for 
powder/liquid acid based cements [51] with the exception of sample dimensions. Cylindrical 
specimens (D = 2 mm and h = 4 mm) were again made by casting the final mixture into silicone 
molds. As schematically shown in Fig. 4.2c, the specimens were placed diametrically between the 





                                               eq (2) 
where P, D and L are the maximum applied load (N), the diameter of the specimen (mm) and the 
height of the specimen (mm), respectively. In spite of the compressive stress at the surface, 
cements fail in tension along the highly stressed diameter (Fig. 4.2c).  
     
Fig. 4. 2. Measuring the DTS of a GIC specimen before (a) and after (b) failure (the crack 
formed within the sample is indicated by the arrow) as well as the schematic of the diametral 








The Vickers microhardness of the GIC samples were measured using a microhardness tester 
(Mitutoyo MVK-H1). For each measurement, a 50 gf load was applied on the samples for 30 s. 
The microhardness value reported here for each GIC is the average of six measurements.  
4.2.4 In vitro studies in simulated body fluid (SBF) 
SBF (pH = 7.4) was prepared according to the protocol outlined by Kokubo et al. [148] and 
stored in a fridge at 4 oC up to one month. Based on the results of the compression, diametral 
tensile and microhardness tests, two sets of GICs exhibiting the best mechanical properties (5 wt% 
Bioglass®-ceramic content) and where the mechanical properties drop (10 wt% Bioglass®-ceramic 
content), were selected for the SBF studies. For this purpose, cylindrical specimens (D = 4 mm 
and h = 6 mm) were prepared as explained in section 2.3.1 and stored at 37 ± 1 °C for 1 h. Each 
GIC specimen was then immersed into 25 ml of SBF at 37 ± 1 °C for various time periods of 1 d, 
3 d, 7 d and 14 d. The SBF was refreshed every 2 days for all systems except for those used to 
monitor the change in pH of the SBF media (n = 3) using a digital pH meter (Hanna; HI 9126). At 
the end of each period of time, the GIC specimens were gently rinsed with distilled water and dried 
in a desiccator at room temperature for up to 2 d.  
The hybrid GICs containing 5 wt% and 10 wt% Bioglass®-ceramic (74% crystallinity) before 
and after 14 d immersion in SBF were further characterized using a Fourier-Transform Infrared 
Spectrometer (FTIR; NEXUS 670 FT-IR) between 650 and 4000 cm-1. Also, the commercial GIC 
after 14 d immersion in SBF as well as the hybrid GICs containing 5 wt% Bioglass®-ceramic (74% 
crystallinity) after 7 d and 14 d immersion in SBF were analyzed by XRD (PANalytical X'Pert 
Pro) using Cu Kα radiation (15° < 2θ < 90°). Note that, only the portions of the XRD patterns and 
FTIR spectra containing useful information are presented here. Also, the morphology of the 
cements after immersion in SBF was examined by SEM.  
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4.3 Results and Discussions 
4.3.1 Optimum degree of crystallinity 
As explained in section 2.3, in order to determine the degree of crystallinity of 45S5 Bioglass®-
ceramic leading to the highest mechanical properties in GICs, a series of preliminary experiments 
were carried out. Fig. 4.3 presents the results of the compression, diametral tensile and 
microhardness tests on the GICs containing 5 wt% Bioglass®-ceramic particles with various 
degrees of crystallinity. As indicated in this figure, GICs containing Bioglass®-ceramic particles 
with 74% crystallinity exhibit a peak in their mechanical properties. Thus, the 45S5 Bioglass®-
ceramic with 74% crystallinity was selected to be incorporated into GICs in this study.  
The mechanical properties of these hybrid GICs depend on the mechanical properties of the 
Bioglass®-ceramic particles as well as their interfacial adhesion with the matrix both of which 
combined appear to simultaneously reach an optimum at ~74% crystallinity. There is an 
amorphous phosphorous-rich (P-rich) phase in this Bioglass®-ceramic [95], which has less 
chemical stability than that of the combeite phase, that may react more readily with the polymeric 
acid of the GIC; similar to that of the original glass of the GIC. As a result of this reaction, Ca2+ 
ions can also leach out of this P-rich phase and partake in the formation of polysalts and the 
hardening process (i.e. setting), improving the interfacial adhesion and integration between the 
Bioglass®-ceramic particles and the GIC matrix. It was previously shown that bioactive materials 
containing Ca and a high amount of non-bridging oxygens (e.g. Bioglass®) are able to react with 
the polymeric acid of GICs [62, 157]. In general, the addition of 45S5 Bioglass® into a 
conventional GIC interferes with the setting reaction and competes with the ionomer glass. The 
high sodium content of Bioglass® results in the release of sodium in the polysalt matrix and 
premature hydrolytic stability and poor cement mechanical properties. Heat treating the 45S5 
Bioglass® to increase its crystallinity, as conducted in this study, reduces its solubility and 
reactivity overcoming the aforementioned problems [62, 157]. Thus, it can be concluded that, 45S5 
Bioglass®-ceramic with 74% crystallinity may contain an optimum balance of combeite and P-rich 
phase contributing to the improved mechanical properties of the particles and their interfacial 






Fig. 4. 3. Effect of the 45S5 Bioglass®-ceramic crystallinity on the compressive strength (a), 




































































4.3.2 Compressive strength  
The compressive strength of hybrid GICs containing various amounts of Bioglass®-ceramic 
particles with 74% crystallinity after 1 d and 7 d soaking in distilled water are presented in Fig. 
4.4. It has been reported in previous studies [61, 149] that the addition of various types of bioactive 
glass particles into conventional GICs can lower their compressive strength. However, our GICs 
containing 2 wt% and 5 wt% Bioglass®-ceramic exhibit slightly higher compressive strength on 
average compared to that of the commercial GIC which can be attributed to the high crystallinity 
(74%) of the Bioglass®-ceramic particles, as explained in section 3.1. By increasing the Bioglass®-
ceramic content to 10 wt% and higher, the compressive strength drops which is further explained 
in the following paragraph. The GICs containing 15 wt% and 20 wt% did not show sufficient 
strength even during handling prior to the test.  
 
Fig. 4. 4. Compressive strength of hybrid GICs containing various amounts of Bioglass®-ceramic 































It has been reported that the compressive strength of GICs increases with longer immersion in 
distilled water [149] due to the fact that the strength, stiffness and insolubility of GICs are 
gradually enhanced through crosslinking of the polymer matrix in a diffusion-controlled process 
[150]. During this process, a hard phase starts to form due to the continuous formation of aluminum 
salt bridges as the Al3+ ions create 3D crosslinks within the GIC [134]. This is consistent with our 
results for GICs containing up to 5 wt% Bioglass®-ceramic where longer soaking in distilled water 
(7 d) increases their compressive strength. However, this trend changes for the GICs containing 
10 wt% Bioglass®-ceramic because their compressive strength decreases after 7 d soaking in water 
(Fig. 4.4). This can be attributed to the fact that the incorporation of excess Bioglass®-ceramic (10 
wt% ≤) can result in a higher number of particles remaining unreacted during the setting process 
and so are loosely attached to the GIC matrix (also observed in the SEM images in section 3.5). 
These loosely attached particles are also responsible for the drop in the compressive strength of 
the hybrid GICs containing excessive amounts of Bioglass®-ceramic particles (10 wt% ≤). Such 
loosely attached particles may detach easily, especially after longer soaking times in distilled water 
(i.e. 7 d), lowering the compressive strength by creating potential crack initiation sites.  
4.3.3 Diametral tensile strength (DTS) 
The DTS of hybrid GICs containing various amounts of Bioglass®-ceramic particles with 74% 
crystallinity after 1 d and 7 d soaking in distilled water are presented in Fig. 4.5. Similar to 
compressive strength, it has been previously reported that the incorporation of bioactive glass 
particles into conventional GICs can decrease their DTS [61, 149]. For our hybrid GICs, the 
incorporation of 2 wt% Bioglass®-ceramic slightly decreases the DTS after 1 d soaking in distilled 
water. However, the DTS of the hybrid GIC containing 5 wt% Bioglass®-ceramic after 1 d and 7 
d soaking in distilled water is higher on average than that of the commercial GIC. Similar to the 
compressive strength results (Fig. 4.4), the DTS drops for GICs containing 10 wt% ≤ Bioglass®-
ceramic (Fig. 4.5), which can be also due to the higher number of loosely attached unreacted 
particles within the GICs, as explained above in section 3.2. Under tension (e.g. DTS 
configuration), cracks can propagate more easily within GICs causing failure due to their inherent 




Fig. 4. 5. DTS of hybrid GICs containing various amounts of Bioglass®-ceramic particles with 
74% crystallinity after soaking for 1d  and 7d  in distilled water (n = 6). 
4.3.4 Microhardness  
The microhardness of hybrid GICs containing various amounts of Bioglass®-ceramic particles 
with 74% crystallinity after 1 d and 7 d soaking in distilled water are presented in Fig. 4.6. The 
results show that for both 1 d and 7 d soaking times, the incorporation of Bioglass®-ceramic 
particles decreases the microhardness of GIC with a drastic drop at 10 wt% ≤ content which is 
similar to the drop observed for the compressive strength and DTS results. Fig. 4.6 also reveals 
that longer soaking time is in favor of the microhardness of GICs due to the continuous formation 
of the hardening phase over time which improves bonding within the GIC matrix. However, at 10 
wt% ≤ incorporation, this reaction is interrupted by the excess Bioglass®-ceramic particles in the 




























Fig. 4. 6. Microhardness of hybrid GICs containing various amounts of Bioglass®-ceramic 
particles with 74% crystallinity after soaking for 1d  and 7d  in distilled water (n = 6). 
 
Based on all the mechanical properties results (Figs. 4.4-4.6), GICs containing 5 wt% 
Bioglass®-ceramic show the best combination of compressive strength, DTS and microhardness. 
4.3.5 Fractography and strengthening mechanisms 
The SEM images of the fracture surface of GICs after the compression test are presented in 
Fig. 4.7. The dehydration cracks, which are common in commercial GICs, are observed in Fig. 
4.7a [151]. In Fig. 4.7 b-f, examples of Bioglass®-ceramic particles embedded within the matrix 
of hybrid GICs are presented. For example, in the hybrid GIC containing 2 wt% Bioglass®-
ceramic, a Bioglass®-ceramic particle bridging the crack surfaces [152] is evident (Fig. 4.7 b and 































crack extension resistance of the GIC. Fig. 4.7d shows a Bioglass®-ceramic particle that has 
formed a cohesive interface with the GIC matrix. Such excellent interfacial adhesion, allowing the 
mechanical stress to effectively transmit [146, 153] from the brittle matrix of the GIC to the 
reinforcing particles, may explain the higher compressive strength and DTS of this hybrid GIC 
containing 5 wt% Bioglass®-ceramic. According to Figs. 4.4-4.6, there was a drop in all 
mechanical properties of GICs containing 10 wt% ≤ Bioglass®-ceramic which was attributed to 
the loosely attached and poorly bonded Bioglass®-ceramic particles to the GIC matrix which can 
be observed in Fig. 4.7 e and f.  
   
   
Fig. 4. 7. SEM images captured from the fracture surfaces (after the compression test) of the 
commercial GIC (a) as well as hybrid GICs containing 2 wt% (b and c), 5 wt% (d), 10 wt% (e) 
and 15 wt% (f) of Bioglass®-ceramic with 74% crystallinity. “P” represents the 45S5 Bioglass®-
ceramic particles 
As discussed, the hybrid GIC containing 5 wt% Bioglass®-ceramic with 74% crystallinity 
exhibits an overall improvement in mechanical properties compared to those of the commercial 
GICs as well as other hybrid GICs containing lower or higher amounts of Bioglass®-ceramic. In 
addition to the excellent interfacial adhesion between the Bioglass®-ceramic particles and the 
matrix (Fig. 4.7d), further characterization of the fracture surface of GIC specimens containing 5 
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enhancement of their mechanical properties (Fig. 4.8). These mechanisms prevent crack formation 
and/or propagation hindering the failure of the GIC under stress. 
   
      
Fig. 4. 8. SEM images captured from the fracture surfaces of the hybrid GIC containing 5 wt% 
Bioglass®-ceramic with 74% crystallinity after the compression test. Various strengthening 
mechanisms induced by the incorporation of Bioglass®-ceramic particles are shown in these 
images (indicated by the arrows): crack deflection (a and b); particle pull-out (c), and crack 
branching (d). Note that, “P” represents the Bioglass®-ceramic particles. 
The crack expansion along the interface of the matrix and a Bioglass®-ceramic particle, 
indicating the crack deflection mechanism, is observed in Fig. 4.8a. In this mechanism, the 
deviation of the crack increases its surface area which dissipates its energy and reduces the stress 
intensity at its tip [145, 153]. Fig. 4.8b shows a crack that was first deflected by the Bioglass®-
ceramic particle and then entered through it where it was stopped from further propagation. This 
mechanism is known as crack-tip shielding which can effectively contribute to increase in the 
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tip, as dislocation mobility is constrained in a brittle Bioglass®-ceramic, which is effectively found 
to lower the stress at the crack tip [154]. Also, an example of the particle pull-out mechanism is 
shown in Fig. 4.8c where the absorbed energy due to the pull-out of the Bioglass®-ceramic particles 
can hinder or stop crack propagation. Fig. 4.8d shows the crack branching mechanism [155] where 
the main crack branches into smaller cracks dissipating its energy [155].  
All these toughening mechanisms explained above can absorb considerable amounts of 
fracture energy, hindering crack propagation within this hybrid GIC containing 5 wt% Bioglass®-
ceramic particles so improving its overall mechanical properties [154]. In our hybrid GICs, the 
mechanically stronger nature of the Bioglass®-ceramic particles (containing combeite crystals) 
compared to that of the Bioglass® particles, effectively demonstrates these strengthening 
mechanisms. 
4.3.6 In vitro studies in SBF 
4.3.6.1 pH measurements 
Fig. 4.9 presents the change in the pH of the SBF media as a function of immersion time for 
the commercial GIC as well as the hybrid GICs containing 5 wt% and 10 wt% Bioglass®-ceramic. 
The pH increases for all combinations after 1 d in SBF followed by a gradual decrease thereafter. 
The initial increase in pH can be related to the ion exchange of Ca2+ in the GICs with H+ in SBF 
resulting in the formation of a hydrated silica layer on the GICs [156]. This hydrated layer provides 
phosphate nucleation sites on the surface of the GICs followed by the formation of HA through 
incorporating OH- from SBF leading to decreasing pH over time [157]. Note that, during this 
period, the pH for GICs containing Bioglass®-ceramic decreases more than that of the commercial 
GIC which can be due to the formation of higher amount of HA, and is in agreement with the 




Fig. 4. 9. Change in pH of SBF as a function of immersion time for the commercial GIC  as 
well as hybrid GICs containing 5 wt%  and 10 wt%  Bioglass®-ceramic particles with 74% 
crystallinity (n = 3). 
4.3.6.2 FTIR  
Hybrid GICs containing 5 wt% and 10 wt% Bioglass®-ceramic were also analyzed by FTIR 
to further study their structures before and after immersion in SBF (Fig. 4.10). The FTIR spectrum 
of the GIC containing 10 wt% Bioglass®-ceramic (Fig. 4.10c) exhibits a peak at 1064 cm−1 
corresponding to Si-O-Si stretching [63] which is stronger than that of the GIC containing 5 wt% 
Bioglass®-ceramic (Fig. 4.10a). This is due to the fact that, the 45S5 Bioglass®-ceramic 
composition has a higher silica content compared to that of the original glass of GICs; thus, 
incorporating more Bioglass®-ceramic leads to higher amounts of Si-O-Si bonds in the hybrid 
GICs. Also, the peak at ~1550 cm-1 (Fig. 4.10 a and c) corresponding to COO- stretching vibration, 
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Fig. 4. 10. FTIR spectra of the hybrid GIC containing 5 wt% Bioglass®-ceramic before (a) and 
after (b) 14 d in SBF and the hybrid GIC containing 10 wt% Bioglass®-ceramic before (c) and 
after (d) 14 d in SBF. 
After 14 d immersion in SBF, two significant changes can be observed in the FTIR spectra of 
the GICs. A peak at 1030 cm−1 appeared in the spectra of both hybrid GICs after 14 d in SBF (Fig. 
4.10 b and d) which is the characteristic peak of PO4
3- and is superimposed over the Si-O-Si peak 
at 1064 cm−1. The intensity of the PO4
3- peak increases by increasing the Bioglass®-ceramic content 
from 5 wt% (Fig. 4.10b) to 10 wt% (Fig. 4.10d), indicating more phosphate precipitation which is 
attributed to the PO4 release from the Bioglass
®-ceramic particles [159]. The second change for 
both GIC systems is the intensification of their absorption band at 1410-1550 cm-1 after 14 d 
immersion which corresponds to the CO3
2- vibration mode [160]. Note that, the CO3
2- band shows 
higher intensity for the GIC containing higher amount of Bioglass®-ceramic (10 wt%), indicating 
greater CO3






































These results suggest that the phase precipitated on the hybrid GICs containing Bioglass®-
ceramic particles after immersion in SBF may be carbonated hydroxyapatite (CHA) which is very 
similar to the mineral phase of dentin. The formation of CHA is also verified by XRD which is 
presented and discussed in the following section.  
4.3.6.3 XRD Characterization 
Based on the FTIR results, both hybrid GICs containing 5 wt% and 10 wt% Bioglass®-ceramic 
showed a similar behavior after 14 d immersion in SBF; thus, the former system (5 wt%), which 
also showed the best overall mechanical properties, was opted for further characterization by XRD.  
The XRD patterns of the commercial GIC after 14 d in SBF and the hybrid GIC containing 5 
wt% Bioglass®-ceramic after 7 d and 14 d in SBF are presented in Fig. 4.11. The XRD pattern of 
the commercial GIC after 14 d in SBF (Fig. 4.11a) reveals no sign of crystalline CHA; whereas, 
two low-intensity peaks related to combeite and CHA, were detected in the patterns of the hybrid 
GIC (Fig. 4.11 b and c) [161]. This verifies that within the timeframe of this in vitro testing (14 
d), the commercial GIC does not remineralize, but with 5 wt% incorporation of Bioglass®-ceramic 
(i.e. the hybrid GIC), it exhibits remineralization. Considering the relatively low Bioglass®-
ceramic content of the hybrid GIC (5 wt%) and the short in vitro studies in SBF (up to 14 d), low 
quantities of CHA was expected to form which is reflected by the low intensity of the CHA peaks 
(Fig. 4.11 b and c). Additionally, a small portion of the Bioglass®-ceramic content is on the surface 
of the GIC and effectively exposed to the SBF medium, which further contributes to the low 
amount of CHA formed. 
This relatively low rate of CHA formation is due to not only the relatively small bioglass-
ceramic content, but also their semi-crystalline nature resulting in a slower dissolution in SBF [98, 
100]. This trend in hybrid GICs is beneficial since it allows the Bioglass®-ceramic particles to not 
only induce remineralization and convert to CHA via a controlled manner and time [142] but also 
serve their reinforcing role by maintaining their strength over time as they dissolve at a lower rate. 
As shown in the XRD patterns (Fig. 4.11 b and c), the peak corresponding to combeite (i.e. the 
reinforcing crystalline phase) remained unchanged indicating its slow dissolution. The 
appropriately low rate of our bioglass-ceramic dissolution and CHA formation can provide 
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sufficient time for the development of improved chemical bonding between the dentine tissue and 
the GIC while its mechanical support is maintained [142]. The Bioglass®-ceramic particles 
embedded inside the GIC, which are in less contact with the physiological fluids, continuously 
contribute to this mechanical support over a long time period. Thus, the hybrid GIC containing 5 
wt% Bioglass®-ceramic not only exhibits improved mechanical (Figs. 4.4-4.6) and remineralizing 
properties, but also can potentially maintain its suitable mechanical properties in vivo serving as a 
reliable dental restorative. 
 
Fig. 4. 11. XRD results for the commercial GIC after 14 d in SBF (a) as well as the hybrid GIC 
containing 5 wt% Bioglass®-ceramic after 7 d (b) and 14 d (c) immersion in SBF.   
4.3.6.4 SEM Analysis 
Fig. 4.12 presents the SEM images captured from the surface of the commercial GIC as well 
as hybrid GICs containing 5 wt% and 10 wt% Bioglass®-ceramic after immersion in SBF for 1 d, 
3 d, 7 d and 14 d.   























Fig. 4. 12. SEM images captured from the surfaces of the commercial GIC (left column) and 
hybrid GICs containing 5 wt% (middle column) and 10 wt% (right column) after 1 d (a-c), 3 d 
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As expected from the XRD results, no typical sign of CHA precipitation is observed on the 
commercial GIC after up to 14 d immersion in SBF (Fig. 4.12 a, d, g and j). On the other hand, 
apatite precipitation [62, 71, 169] is observed on the hybrid GICs containing 5 wt% and 10 wt% 
Bioglass®-ceramic after 1 d immersion in SBF (Fig. 4.12 b and c). Immersion in SBF for 3 d (Fig. 
4.12 e and f) resulted in a smoother surface, which may be attributed to the formation of an 
incipient apatite coating [71]. These precipitates tend to grow into different apatite morphologies 
over various immersion times in SBF (Fig. 4.12 e, f, h, i, k, l) [61, 71] which can be partly due to 
the gradual incorporation of carbonate ions into the apatite structure [162]. Three-dimensional 
discrete islands of apatite appeared on the GIC surface with longer immersion times (Fig. 4.12 i, 
k and l). 
4.4 Conclusions 
In this study we improved the mechanical and remineralizing properties of a commercially 
available GIC by the incorporation of 45S5 Bioglass®-ceramic particles containing a mechanically 
strong combeite phase (Na2Ca2Si3O9). We showed that the hybrid GIC containing 5 wt% 
Bioglass®-ceramic with 74% crystallinity has the highest overall mechanical properties based on 
the results of the compression strength, diametral tensile strength and microhardness tests. For 
these samples, the average compressive strength and DTS values were respectively increased by 
15% and 60% after 7 days immersion in distilled water, when compared to those of the 
corresponding commercial GIC. 
Strengthening mechanisms including crack deflection, crack branching, crack-tip shielding 
and particle pull-out contributing to the mechanical performance enhancement were observed and 
discussed for this hybrid GIC. The overall mechanical properties of other hybrid GICs with higher 
Bioglass®-ceramic contents (e.g. 10 wt%) dropped due to the larger number of loosely attached 
particles acting as crack initiation sites. Furthermore, the results of the in vitro studies revealed 
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5 Chapter 5 
Development of aluminum-free glass ionomer cements using 45S5 
Bioglass® and its Bioglass®-ceramic 1 
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Abstract. Although the incorporation of bioactive glasses into glass ionomer cements (GICs) has 
led to promising results, using a bioactive glass as the only solid component of GICs has never 
been investigated. In this study, we produced an Al-free GIC with standard compressive strength 
using various combinations of 45S5 Bioglass® and its glass-ceramic as the solid component. The 
glass-ceramic particles with 74% crystallinity were used for this purpose as they can best act as 
both remineralizing and reinforcing agents. Strengthening mechanisms including crack deflection 
and crack-tip shielding were activated for the GICs containing 50-50 wt% Bioglass® and 
Bioglass®-ceramic as the optimum ratio. We monitored and verified the progression of the GIC 
setting reaction at its early stages. We also discussed that our bimodal particle size distribution 
containing both micron- and nanosized Bioglass® and Bioglass®-ceramic particles may enhance 
the packing density and integrity of the structure of the cements after setting. In such GICs 
produced in this study, the toxic effects of Al are avoided while chemical bonds are expected to 
form between the cement and the surrounding hard tissue(s) through interfacial biomineralization 
and adhesion. 
Keywords: Glass ionomer cements; Mechanical Properties; Bioactive; 45S5 Bioglass®; 45S5 
Bioglass®-ceramic; Aluminum-free GIC   
 
 




Glass ionomer cements (GICs), also known as glass polyalkenoates, were developed and 
patented in 1969 at the Laboratory of the Government Chemist (London, UK) [14]. Since then, 
GICs have been extensively studies and used as luting, sealing and restorative materials in modern 
dentistry [171, 172]. GICs exhibit many clinical advantages compared to other restoratives 
including the ability to develop physicochemical bond to hard tissues, low coefficient of thermal 
expansion, desirable translucency and proper biocompatibility with the pulp tissue and primary 
cultures of bone cells – all of which can significantly promote their in vivo performance [16, 173].  
GICs are classified as acid-base cements consisting of an aqueous solution of a polyalkenoic 
acid and a powdered calcium aluminosilicate glass component with a basic nature [150]. The 
polyalkenoic acid is a family of complex acids normally including polyacrylic acid (PAA) or an 
acrylic/maleic/itaconic acid copolymer. During the acid-base setting reaction, multivalent 
counterions (e.g. Ca2+ and Al3+) leach out from glass particles resulting in the crosslinking of 
polyalkenoic acid chains [16, 163], which leads to cement hardening. 
In addition to the field of dentistry, GICs have been considered as a potential substitute for 
polymethylmethacrylate (PMMA) bone cements for orthopedic applications due to their ability to 
chemically bond to hydroxyapatite (HA) [164]. Unlike PMMA-based bone cements, GICs exhibit 
good adhesion to hard tissue, proper stability in aqueous environment, low shrinkage and low 
exothermic setting reaction [135, 165, 175]. Despite all the advantages, the reliance of GICs on 
the presence of Al has restricted their application in orthopedics and dentistry. Al ion is recognized 
as a neurotoxin which promotes cellular oxidation [69] and disrupts cellular homeostasis [70]. 
There have been reports of aluminum traces in the brain, cerebral spinal fluid, blood and urine up 
to 77 days after implanting an aluminum-containing bone cement [71]. This issue has also been 
implicated in and linked to the pathogenesis of many neurological disorders such as Parkinson’s 
disease [72]. Due to the concerns about the release of Al ions from GICs, there has been a growing 
interest towards the development of Al-free glass ionomer cements for both dentistry and 
orthopedics applications [71]. Also, the existing formulations of conventional GIC suffer from 
poor mechanical properties limiting their applications in high stress-bearing areas of the body. 
Attempts have been made to overcome this drawback including the incorporation of glass fibers 
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[139] or metallic oxide (nano-) particles [140]; glass composition modification [70] and using 
novel polyacids [166]. In our previous work [64], it was shown that the incorporation of an 
optimum amount of 45S5 Bioglass®-ceramic with certain degree of crystallinity containing 
mechanically strong combeite (Na2Ca2Si3O9) phase could improve the mechanical performance of 
GICs while enhancing their remineralizing properties [64].  
GICs can be considered bioactive since they can release ions via dissolution of calcium 
aluminosilicate glass particles causing certain biomineralization within their clinical environment 
[142]. Improving GICs remineralizing properties can potentially lead to a stronger chemical bond 
between the native tissue(s) and the cement in vivo. Although the incorporation of various 
bioactive glass or ceramic fillers into GICs has been investigated for this purpose [61, 64, 65], 
utilizing bioactive glass particles as the whole solid powder component of the cement has never 
been previously studied. If the used bioactive glass in such a GIC transforms into HA in a 
controlled manner, the hard tissues surrounding the GIC can take advantage of the resulting 
interfacial biomineralization and adhesion [142].  
45S5 Bioglass® (45 wt% SiO2, 24.5 wt% Na2O, 24.5 wt% CaO, 6 wt% P2O5) is known to be 
the first commercial bioactive glass [77]. Developed by Hench in late 70’s, this bioglass was the 
first material that was able to form a stable bond with tissues through the formation of an apatite 
layer [77, 107]. 45S5 Bioglass® has similar characteristics to the common GIC glass component. 
For instance, it contains high volume of network modifiers, CaO and Na2O, that can break the 
continuous Si–O–Si structural units resulting in formation of non-bridging oxygens [1]. Upon 
incubation in an aqueous environment, 45S5 Bioglass® participates in cation exchange of Na+, 
Ca2+ with H+ from the solution [61]. When this bioglass is mixed with polyacid solution, the 
released Ca2+ ions may be able to react with the polyacrylate chains creating an ionically 
crosslinked polyacrylate matrix [1, 178], similar to the setting reaction in conventional GICs. 
Furthermore, PO4
3- is released from the Bioglass® as a result of reacting with the polyacid [61]. It 
has been shown that the existence of phosphorous (along with Si) within the matrix results in 
formation of an inorganic network which interpenetrates with the aforementioned Ca2+ 
polyacrylate matrix [167]. Formation of this network contributes to insolubility of GICs as well as 
their gradual increase in compressive strength with time [168].  
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Due to its high bioactivity index [107], 45S5 Bioglass® can be overreactive with polyacid 
resulting in a premature setting. Alternatively, 45S5 glass-ceramic with appropriately lower 
bioactivity (i.e. reaction/dissolution rate) and superior mechanical properties compared to those of 
the 45S5 Bioglass® may be used as the GIC glass component [95].  
Due to lack of Al, 45S5 Bioglass® might not have high basicity as other GIC glass 
compositions [61]. It has been reported that reducing the particle size of the glass component in 
GICs increases its reactivity [151], resulting in higher setting rates which can make up for the less 
reactivity caused by the lack of Al in the Bioglass® composition.  
The main objective of this study was to develop a remineralizing, aluminum-free GIC 
consisting of an optimum ratio of 45S5 Bioglass® to its glass-ceramic as the glass component as 
well as polyacrylic acid aqueous solution. The new resulting GICs exhibited proper mechanical 
properties comparable to commercially available GICs. We also show that our 45S5 Bioglass®-
based GIC not only meets the ISO compressive strength requirement but also may improve the 
remineralizing properties of cements.  
5.2 Materials and methods 
5.2.1  Bioglass® synthesis, heat treatment and characterization 
The 45S5 Bioglass® used in this research was prepared and donated by Dr. Robert Hill from 
Queen Mary University of London. In short, calculated amounts of high-purity precursors were 
mixed and then melted in a platinum/rhodium crucible at 1380 ℃ for 1 h using an electric furnace. 
The resulting melt was then rapidly quenched in deionized water at room temperature. Next, the 
frit was dried and melted again for 30 min. followed by a grinding process using a vibratory mill 
[64, 95, 119].  
To eliminate any internal stress created during grinding process, the as-received Bioglass® was 
annealed at 460 °C for 8 h under ambient atmosphere. X-ray diffraction (XRD; PANalytical X'Pert 
Pro) using Cu Kα radiation (10° < 2θ < 90°) was used to confirm that the amorphous nature of the 
material was completely retained. 
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In order to prepare the 45S5 Bioglass®-ceramic containing combeite, the as-received 45S5 
Bioglass® was heat treated through a controlled process [95] to induce 74% crystallinity in its 
structure which was previously reported to be the optimum crystallinity, leading to the highest 
mechanical performance when incorporated into GICs [64]. The heat treatment profiles used to 
obtain various degrees of combeite crystallinity in 45S5 Bioglass® are explained in detail in our 
previous study [95]. The heat-treated glass was then lightly ground using an agate mortar and 
pestle. Particle size distribution of the as-received glass and heat-treated glass-ceramic was 
measured via laser light scattering particle size distribution analysis (PSA; Horiba LA-920) using 
isopropyl alcohol as a dispersant and after 5 minutes in an ultrasonic bath. Note that the refractive 
indices of 1.55 and 1.08 were respectively used for the 45S5 Bioglass® and isopropyl alcohol. 
Also, morphology of the as-received glass and heat-treated glass-ceramic particles was examined 
using a scanning electron microscope (SEM; HITACHI, S-3400N).  
5.2.2 Cement preparation 
The glass component of our cements was prepared by mixing of 45S5 Bioglass® and 45S5 
Bioglass®-ceramics (74% crystallinity). In order to investigate the effect of incorporation of 
Bioglass®-ceramic, eleven powder mixtures containing 0, 10, 20, 30, 40, 50, 60, 70, 90 and 100 wt% 
Bioglass®-ceramic (C0, C10, C20, …, C100; Table 5.1) were prepared using a Coulter mixer for 
30 min. to reach homogeneity. Note that, the materials codes and details of the glass powder 
components are given in Table 5.1. 
A 50 wt% aqueous solution of PAA, Mw = 240,000 g/mol (Acros Organics) in deionized water 
was used as the liquid component of the cement. The glass powder components were hand-mixed 
with the liquid component on a watch glass at different ratios. The powder to liquid ratio (P:L) 
with the best working and handling properties (P:L = 1:0.8) was found by trial and error among 
ten tested ratios ranging from 1:0.4 to 1:2.2. Note that, all the samples were prepared at room 
temperature (21 ± 2 °C) throughout this process. Depending on the subsequent characterization 
technique, different setting procedures were followed as explained in the next section.   
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5.2.3 Cement properties 
The setting time of each cement was recorded (n = 3) according to ISO 9917-1: dentistry-
water-based cements [51]. Compression tests were carried out according to the same standard [51]. 
Cylindrical-shaped cements were made at ambient temperature (21 ± 2 °C) by casting the mixed 
materials into silicone molds (D = 4 mm and h = 6 mm) followed by an hour incubation at 37 ± 1 
°C. Samples were then removed from the molds and incubated in distilled water at 37 ± 1 °C for 
various durations of 1 h, 1 d, 3 d, 7 d, 14 d, 21 d and 42 d. After each timepoint, samples were 
tested using an Instron 3382 Universal Testing Machine with a 5 kN load cell at a crosshead speed 






              eq (1) 
 
where P is the maximum applied load (N) and D is the diameter of the sample (mm). The fracture 
surface of the cements was examined by SEM.  
A microhardness tester (Mitutoyo MVK-H1) was also used to measure the Vickers 
microhardness of all the cements by applying a 50 gf load on the surface of each cement for 30 s 
(n = 6).      
The resulting cements were characterized by Fourier transform infrared spectroscopy (FTIR, 
Thermo Scientific, Nicolet iS10) at room temperature over wavenumber range of 500 to 4000 cm-
1. Each FTIR experiment was performed at the high resolution of 1 cm-1 over 64 scans. However, 
only the portions of the FTIR spectra containing useful information are presented here. To examine 
the effect of the powder composition, the FTIR spectra of the C0, C50 and C100 cements after 7 
d immersion in distilled water (DW) were obtained and studied. To study the effect of immersion 
time, the C50 cements, which exhibited the highest mechanical properties among all compositions, 
were examined by FTIR after 1 d, 7 d and 21 d immersion in DW. To investigate the early stages 
of setting, spectra were collected from the C50 composition at 1, 3, 5, 7, 10, 15, 20 and 25 minutes 
immediately post mixing (n = 3). To monitor the setting progress of the C50 cement, the band 
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intensity ratios between the free carboxyls (COOH) absorption band at ≈ 1650 cm-1 to the Ca-
polyacrylate (COO− Ca2+) absorption bands at ≈ 1550 cm-1 and 1410 cm-1 [169, 174, 179, 183] 
were computed from each FTIR spectrum and the differences in the COO− Ca2+/COOH band 
intensity ratios as a function of setting time (1, 3, 5, 7, 10, 15, 20 and 25 min) were plotted.  
5.3 Results and discussions 
5.3.1 Bioglass® characterization 
The XRD patterns, the PSA results (particle size distribution) and the SEM micrographs of 
both as-received Bioglass® and the heat treated Bioglass®-ceramic particles with 74% crystallinity 
are presented in Fig. 5.1. The XRD pattern of Fig. 5.1a confirms that the as-received Bioglass® 
has retained its amorphous nature after the stress-relief heat treatment at 460 °C as explained in 
section 2.1. Also, the XRD pattern of Fig. 5.1b reveals that the Bioglass®-ceramic powder contains 
solely combeite crystalline phase. The particle size of Bioglass® powder (Fig. 5.1a) is in the range 
of 0.3 to 90 µm with an average of 4.6 µm. The wide bimodal distribution in this graph consists of 
two major populations of submicron and micron-sized particles. On the other hand, the particle 
size distribution of Bioglass®-ceramic particles (Fig. 5.1b) shows a slight shift to larger particle 
size (ranged from 0.3 to 100 µm; mean size = 6.3 µm) while maintaining a similar bimodal 
distribution. The shift to larger size and the decrease in intensity of submicron peak can be the 
result of heat treatment which might lead to slight agglomeration. These characterization results 
are important since particle size can significantly affect the mechanical properties of cements [151, 
180]. GICs prepared by the powders with a bimodal particle size distribution, are shown to have 
higher fracture toughness and improved workability properties. This is due to the fact that, such 
distribution leads to a high packing density of the glass particles within the cement matrix in which 
fine particles mostly provide the reactive surface area required for setting reaction (i.e. faster 
setting times) whilst coarse particles may mainly contribute to the strengthening mechanisms (i.e. 
crack deflection) [160, 170, 180]. In the absence of Al as an important element in 3D polysalt 
formation and hardening of the cements [16], particle size distribution can play a significant role 




Fig. 5. 1. XRD patterns, particle size distributions and SEM micrographs of a) the as-received 
Bioglass® powder and b) heat treated Bioglass®-ceramic particles with 74% crystallinity. The 
XRD patterns are adapted with permission from [29]. Copyright 2014, Elsevier.   
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  In the SEM images (Fig. 5.1), submicron and micron-sized glass particles can be observed 
in both as-received Bioglass® (Fig. 5.1a) and the Bioglass®-ceramic (Fig. 5.1b) powders which is 
consistent with the PSA results. The SEM images also show submicron particles which are 
agglomerated onto the micron-sized particles which seems to be more in the case of heat-treated 
powder (Fig. 5.1 b). This may happen due to the higher surface energy of sub-micron particles 
which increases their tendency to agglomerate [107].  
5.3.2 Cement properties 
The powder/liquid (P:L) ratios and setting times of all cements are presented in Table 5.1. The 
P:L of 1:0.8 which was the highest ratio that delivered the best working and handling properties, 
was obtained by trial and error. It has been shown that higher P:L can result in better mechanical 
performance in GICs due to the development of more polysalt bridges which results in higher 
degree of crosslinking [170]. According to this Table, the setting time increases with increasing 
the Bioglass®-ceramic content of the cements. This can be attributed to the lower reactivity of the 
Bioglass®-ceramic particles compared to that of the amorphous Bioglass® [100] resulting in slower 
reaction with polyacrylic acid (i.e. delayed setting process). 
Table 5. 1. Bioglass® and Bioglass®-ceramic contents; powder to liquid ratios; and setting times 






P:L (g/g) ** 
Setting time 
(min.) 
C0 0 100 1:0.8 6.5 ± 1.2 
C10 10 90 1:0.8 6.8 ± 2.2 
C20 20 80 1:0.8 7.9 ± 1.7 
C30 30 70 1:0.8 8.7 ± 3.3 
C40 40 60 1:0.8 8.6 ± 2.6 
C50 50 50 1:0.8 9.1 ± 2.4 
C60 60 40 1:0.8 10.6 ± 2.8 
C70 70 30 1:0.8 10.8 ± 3.4 
C80 80 20 1:0.8 15.4 ± 3.7 
C90 90 10 1:0.8 18.1 ± 3.4 
C100 100 0 1:0.8 22.7 ± 3.2 
* As mentioned, all Bioglass®-ceramics used in this study have 74% crystallinity.  
** Note that the liquid component consists of 0.4 g polyacrylic acid and 0.4 g water (50 wt%). 
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It has been reported that the metallic ions (e.g. Ca2+) in 45S5 Bioglass® glass network can be 
released upon reacting with PAA and take part in setting reaction [61]. The setting times of 45S5 
Bioglass®-based GICs (Table 5.1) are longer than the range of 1.5 to 6 min. required by ISO 9917-
1:2002 standard for GICs when used as restorative materials. The prolonged setting times may be 
resulted from the absence of Al component limiting the ability of the cements from forming 
polysalt bridges at higher rates upon mixing. Even though our GIC still can be considered for other 
glass ionomer cement applications [51], the resulted setting times can be reduced by manipulating 
different parameters such as particle size, polyacid composition, etc. 
Fig. 5.2. shows the SEM micrographs for the C0, C20, C50 and C100 cements after setting. 
All micrographs show a high packing density in the cements structures which is partly due to the 
bimodal particle size distribution (Fig. 5.1). Such distribution of particle size is shown to have a 
two-fold effect on setting time and mechanical properties of the GICs as explained in section 3.1. 
In the structure of C0 and C20 cements (Fig. 5.2a and b), more loosely attached particles can be 
observed. The setting reaction rate for these systems may be too high such that a fraction of the 
glass particles were remained unreacted (i.e. loosely attached). Interestingly, the SEM images of 
C100 cement (Fig. 5.2d) show a similar microstructure containing many loosely attached particles. 
This is attributed to the fact that the Bioglass®-ceramic content of C100 cement is less reactive 
compared to the fully amorphous glass content of other cements [100] resulting in unreacted 
particles which are poorly attached to the matrix. On the other hand, in the C50 cement micrograph 
(Fig. 5.2c), the particles are shown to be more integrated and attached to the cement matrix. Thus, 
C50 cement containing 50 wt% Bioglass® and 50 wt% Bioglass®-ceramic with bimodal particle 
size distributions may present an optimum composition where the submicron Bioglass® particles 
have sufficient surface area to fully react with PAA, while the larger particles, in particular the less 
reactive glass-ceramic particles, are allowed to be embedded within the matrix during this setting 
process. This also explains the high mechanical properties of the C50 cement which is discussed 
in the next section. 
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Fig. 5. 2. SEM images captured from the surface of a) C0, b) C20, c) C50 and d) C100 cements 
after setting. 
5.3.2.1 Mechanical properties 
The results of the compression and microhardness tests performed on the cements containing 
various amounts (Table 5.1) of Bioglass®-ceramic particles are presented in Fig. 5.3. Both 
compressive strength and microhardness have been improved for all cements containing 
Bioglass®-ceramic up to 60 wt% compared to those of C0 cement (i.e. the control cement 
containing no Bioglass®-ceramic). Note that, the C50 cement exhibits the highest combination of 
both compressive strength and microhardness among all cement compositions. The strengthening 
mechanisms that can contribute to the high mechanical properties of this cement are discussed at 
the end of this section based on SEM images. Higher mechanical properties of the C50 cements 
can be attributed to the higher strength of the Bioglass®-ceramic compared to that of the Bioglass® 
[99] making C50 a cement with stronger reinforcing agent than those with less Bioglass®-ceramic 
content. Besides, C50 was shown to have an optimum composition (50 wt% Bioglass®, 50 wt% 
Bioglass®-ceramic) leading to a high packing density (Fig. 5.2c). Cements containing more than 
b a 
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50 wt% Bioglass®-ceramic in their solid component, exhibit a constant decrease in their 
compressive strength and microhardness. The reactivity of bioactive glasses is known to decrease 
upon crystallization [100]. Therefore, Bioglass®-ceramic is considered less reactive with PAA 
compared to the Bioglass®. Incorporation of the excess amounts of Bioglass®-ceramic (50 wt% ≤) 
may interfere with the setting reaction which results in more unreacted particles remaining in the 
system (e.g. Fig. 5.2d).  
According to ISO 9917-1:2002 standard, the minimum compressive strength for a clinically 
acceptable GIC as restoratives is 100MPa [19, 51] which reveals that C30, C40 and C50 cement 
groups are in compliance with the compressive strength requirements of this standard. A 
comparison between our GICs and a few commercially available GICs reveals that C50 has higher 
compressive strength (~114 MPa on the average) than Fuji IX (99 MPa) and Vitro Molar (70 MPa) 
[138, 181, 171]. Also, the microhardness of the C50 cement (~72 HV on the average) is 
comparable to that of the α-Fil (87 HV), Fuji II (83 HV) and Ketac Molar Easymix (73 HV) [138, 
181, 171]. Note that, all the aforementioned commercial GICs contain Al, whereas our GIC is Al-
free. Even though the 45S5 Bioglass® composition lacks aluminum and it was not originally 
designed to be used in GICs, these results show that Al-free 45S5 Bioglass®-based cements are 
promising and can compete with commercially available GICs in terms of mechanical 
performance.  
 
Fig. 5. 3. Compressive strength and microhardness of cements containing various amounts of 















































To further investigate the active strengthening mechanisms, the fracture surface of the C50 
cement, which demonstrated the highest mechanical performance, was analyzed using SEM (Fig. 
5.4). Fig. 5.4a shows a crack that is entering into an embedded submicron particle where it is 
stopped from further propagation (denoted with a circle) which is known as crack-tip shielding 
mechanism that can effectively contribute to the improvement of toughness in brittle materials 
[154]. A similar mechanism can be also observed in Fig. 5.4b. In this mechanism, the stress at the 
crack tip is decreased by the formation of a dislocation cloud around the crack tip constraining the 
crack growth. Fig. 5.4c demonstrates another mechanism known as crack deflection mechanism 
where a crack deviates from its original path when it is encountered with a reinforcing agent (i.e. 
a Bioglass®-ceramic particle). In this mechanism, the increased crack surface due to the deflection, 
reduces the stress intensity at the crack tip and dissipates its energy [145, 172]. Fig. 5.4d and 4e 
show the fracture surface of the C50 cement and a commercial GIC (Chemfil Rock, Dentsply), 
respectively. It can be observed that the fracture surface of the C50 cement has a grainy, rough 
structure similar to that of the commercial GIC revealing the significant fracture surface energy 
consumed upon failure. 
 
 
Fig. 5. 4. SEM images captured from the fracture surface of the C50 cement after the 
compression tests (a, b and c). The circles and arrows indicate crack-tip shielding (a and b) and 
crack deflection mechanisms (c), respectively. Fig. 5.4d and 4e show the fracture surface of the 
C50 cement and a commercial GIC (Chemfil Rock, Dentsply), respectively. 
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In Fig. 5.5 the effect of immersion time in DW on compressive strength and microhardness of 
the C50 cement, which exhibited the best mechanical properties (Fig. 5.3), is presented. Longer 
immersion in DW has been reported to improve the compressive strength of GICs [149]. During 
GIC setting, there is a progressive diffusion-controlled process that forms a hard phase due to the 
continuous crosslinking of the polyacrylate chains. The presence of Si and P within the matrix 
results in formation of an inorganic network interpenetrating with the metal (e.g. Ca2+) 
polyacrylate one. Formation of such inorganic network along with the aforementioned hard phase, 
leads to a gradual improvement in the strength, stiffness and insolubility of GICs over time, even 
after the setting [150]. This is consistent with our mechanical properties results (Fig. 5.5) for the 
C50 cement showing that immersion in DW up to 7 d increases the compressive strength and 
microhardness of this cement. However, the compressive strength and microhardness of the C50 
cement gradually decrease for immersion times longer than 7 d and 14 d, respectively. This can be 
attributed to the presence of unreacted particles within the set cement (previously observed in Fig. 
5.2). Such loosely attached particles may be detached more easily from the matrix over longer 
immersion times in DW, creating potential crack initiation sites which may result in lower 
mechanical properties. 
 
Fig. 5. 5. The effect of immersion time in DW on compressive strength and microhardness of the 















































With applying some adjustments, even higher mechanical properties may be obtained for these 
cements. According to the PSA results (Fig. 5.1a and b), more than 70 vol% of the particles in 
both 45S5 Bioglass® and Bioglass®-ceramic particles are submicron. Since these particles provide 
a large surface area to react with PAA, there may be insufficient number of ionomer available to 
effectively hold the large amount of submicron particles resulting in those particles to remain 
unreacted and unattached to the matrix of the cements and lowering their strength. This might be 
also the reason for relatively low P:L ratio of the cements in this study (1:0.8) reported in Table 
5.1. It has been previously shown that low P:L ratios, may lead to lower mechanical properties 
(e.g. decreased compressive strength values) [173]. Having a bimodal particle size distribution 
consist of two equally populated submicron and micron-sized ranges, may not only reduce the 
number of unreacted submicron particles, but also allow higher P:L ratios and potentially enhance 
the mechanical performance.  
5.3.2.2 FTIR analysis 
The FTIR spectra showing the effects of powder composition and immersion time on the 
structure of our Bioglass®-based GICs are presented in Fig. 5.6. The absorption bands at 1410 cm-
1 and 1550 cm-1 respectively correspond to the symmetric and asymmetric stretching vibration of 
Ca-polyacrylate complex (COO− Ca2+) and the peak at 1050 cm-1 is assigned to silicic acid 
(H2SiO3) formation [170, 183, 184]. Ca-polyacrylate formation is the result of PAA ionic 
crosslinking which utilizes cations (i.e. Ca2+) leaching out of the glass particles [158]. Also, silicic 
acid is the result of the dissolution of SiO2 glass network when attacked by PAA [73].  
Fig. 5.6a presents the FTIR spectra of the C0, C50 and C100 cements. The spectrum of the 
C50 cement shows the highest peak intensity for both COO− Ca2+ and H2SiO3, among the three 
spectra, which may indicate a higher degree of crosslinking that is in line with its superior 
mechanical properties (Fig. 5.3). The FTIR spectra of the C50 cement after 1 d, 7 d and 21 d 
immersion in DW are presented in Fig. 5.6b. It can be observed that by increasing the immersion 
time, the intensity of both COO− Ca2+ and H2SiO3 peaks increases which can be due to the 





Fig. 5. 6. FTIR spectra of the C0, C50 and C100 cements after 7 d immersion in DW (a); and the 
C50 cement after 1, 10 and 20 days of immersion in DW (b). 
Using FTIR, the complex formation process of our GICs is assessed in situ over the initial 
25 minutes of setting (Fig. 5.7) through monitoring the changes in absorbance ratio of complexed 
to free carboxyls [183, 184]. Fig. 5.7 shows the change in the intensity of the COOH (1650 cm−1) 
and the COO− Ca2+ (1550 cm−1) peaks for our Bioglass®-based GIC (C50) over time. It appears 
that, the intensity of the COO− Ca2+ peak increases over time at the expense of the COOH peak. 
This gradual time-dependent change can be an indication for the progression of the acid-base 
reaction until the GIC sets [179, 183, 184]. The released Ca2+ ions from the glass particles start to 
create salt bridges which crosslink the polyacrylate chains and lead to a decrease in COOH (1650 























cm−1) and asymmetric (1550 cm-1) Ca-polyacrylate (COO− Ca2+) bonds increases. The progression 
of the GIC setting reaction is further assessed by plotting the COO− Ca2+/COOH ratios (i.e. the 
ratio of 1550 cm−1 to 1650 cm−1 and 1410 cm−1 to 1650 cm−1) over time (the subplot in Fig. 5.7). 
The COO− Ca2+/COOH ratio increases over time indicating the increase in concentration of the 
crosslinked carboxylates and the progressive nature of the setting reaction in our GICs [183, 184].  
 
Fig. 5. 7. Change in intensity of the absorbance peaks of COO− Ca2+ (1550 cm-1) and COOH 
(1650 cm−1) during FTIR analysis of the C50 system as a function of time. The subplots in the 
upper left of spectra depicts the ratio of 1550 cm−1 to 1650 cm−1 ( ) and 1410 cm−1 to 1650 
cm−1 ( ) band intensities (n = 3). Note that the peak assigned to symmetric vibration band of 















































In this study, we produced an Al-free 45S5 Bioglass®-based GIC with standard 
compressive strength comparable to that of the commercially available GICs. We showed that 
the cements with the solid component containing 50 wt% Bioglass® and 50 wt% Bioglass®-
ceramic (74% crystallinity) exhibited the highest combination of compressive strength and 
microhardness. Strengthening mechanisms such as crack deflection and crack-tip shielding 
were found to be activated enhancing the mechanical properties of this group of GICs. Also, 
cements with lower (e.g. 10 wt%) and higher (e.g. 100 wt%) Bioglass®-ceramic contents 
showed many loosely attached particles in their microstructure acting as crack initiation sites. 
It was also discussed that the bimodal particle size distribution of the solid component in these 
GICs may have contributed to their high packing density and structural integrity after setting 
where smaller particles mostly take part in the setting reaction while larger particles participate 
in strengthening mechanisms e.g. crack deflection. Supplementary in vitro and in vivo tests are 
required in the future to further study these 45S5 Bioglass®-based GICs and their performance 
as dental restorative and/or bone cements.   
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6 Chapter 6 
6.1 Summary of conclusions 
In this study new hybrid GICs with improved mechanical and remineralizing properties 
were developed by incorporation of 45S5 Bioglass®-ceramic particles.  
A comprehensive set of heat treatment regimes were presented providing the possibility of 
tailoring the crystallinity of 45S5 Bioglass® from 5% up to 100% by controlling the nucleation and 
growth of mechanically strong phase of combeite (Na2Ca2Si3O9) as the only crystalline phase 
present in the system. Such heat treatments can be used to produce Bioglass®-ceramics with 
appropriate degree of crystallinity for specific applications such as bone regeneration and additives 
for dental restoratives.  
The results of DSC and XRD analyses on a melt-derived 45S5 Bioglass® powder were used 
to develop the heat treatment profiles. The same results were used to calculate the crystallization 
energy (E = 192 kJ/mol) for and obtain the Avrami exponent (n = 0.71) of combeite which were 
then used to explain its crystallization mechanism. The crystallization energy was calculated using 
three numerical methods namely the Kissinger, the Ozawa and the Yinnon methods. The enthalpy 
of crystallization (ΔH) was recorded as 153 ± 4 J/g and it was shown to be independent of the 
heating rate.  
The SEM/EDS results showed that the combeite crystallization mostly occurred on the 
surface of the particles. The microstructural analysis showed that the size of the combeite crystals 
increased up to 27 nm by increasing the heat treatment temperature from 650 ℃ and 800 ℃. Two 
distinct elemental distribution patterns within and between the grains were reported by X-ray 
mapping analysis. The intergranular region between the combeite crystals was shown to be the P-
rich amorphous phase which was preferentially dissolved during etching due to its lower chemical 
stability compare to that of combeite.  
The mechanical and remineralizing properties of a commercially available GIC was 
enhanced through the incorporation of 45S5 Bioglass®-ceramic particles containing a 
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mechanically strong combeite phase (Na2Ca2Si3O9). Based on the results of the compression, 
diametral tensile and microhardness tests, the 45S5 Bioglass®-ceramic with 74% crystallinity was 
shown to deliver the highest overall mechanical properties when incorporated into the GIC. The 
45S5 Bioglass®-ceramic with 74% crystallinity was reported to contain an optimum balance of 
combeite and P-rich phase contributing to the improved mechanical properties of the particles and 
their interfacial adhesion with the GIC matrix, respectively.  
It was shown that the hybrid GICs containing 5 wt% Bioglass®-ceramic with 74% 
crystallinity had higher compressive strength and diametral tensile strength compared to that of 
the commercial GIC. It was reported that after 7 days immersion in distilled water that the 
compressive strength and diametral tensile strength of these samples were improved by 15% and 
60%, respectively, compared to those of the commercial GIC. Strengthening mechanisms 
including crack deflection, crack branching, crack-tip shielding, and particle pull-out were 
reported and discussed as contributing to the mechanical performance enhancement for this hybrid 
GIC. It was also shown that the longer soaking times of the GICs containing up to 5 wt% 
Bioglass®-ceramic in distilled water (7 days) improved their compressive strength. It was reported 
that the incorporation of excess Bioglass®-ceramic (10 wt% ≤) resulted in a high number of loosely 
attached particles which detach easily from the GIC matrix, thus diminishing the compressive 
strength and diametral tensile strength by creating potential crack initiation sites. 
The in vitro studies in SBF showed that the pH increased after 1 d immersion in SBF 
followed by a gradual decrease thereafter. The pH increase was shown to be due to ion exchange 
of Ca2+ in the GICs with H+ in SBF and formation of a hydrated silica layer on the GICs. The pH 
decrease was demonstrated to be the result of the formation of carbonated hydroxyapatite through 
incorporating OH- from SBF which was later verified and confirmed by XRD results.  
It was reported that the CHA was formed at a low rate which can be beneficial for the 
hybrid GIC containing 5 wt% Bioglass®-ceramic as it allows the Bioglass®-ceramic particles to 
not only provide sufficient time for the development of improved chemical bonding between the 
dentine tissue but also play their reinforcing role by maintaining their strength over time and 
serving as a reliable dental restorative. The apatite precipitation was observed by SEM analysis on 
the hybrid GICs containing 5 wt% and 10 wt% Bioglass®-ceramic after 1 d immersion in SBF 
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which was shown to grow into various apatite morphologies (e.g. three-dimensional discrete 
islands) by increasing the immersion times.  
An Al-free 45S5 Bioglass®-based GIC with standard compressive strength comparable to 
that of the commercially available GICs was developed. The setting time of developed cements 
with the powder to liquid ratio (P:L) of 1:0.8 ranged from 6.5 ± 1.2 to 22.7 ± 3.2 min. It was reported 
that the GICs containing 50-50 wt% Bioglass® and Bioglass®-ceramic (C50) resulted in the highest 
mechanical performance with compressive strength of 114 ± 10 MPa and microhardness of 72 ± 
7 HV. It was shown that the strengthening mechanisms such as crack deflection and crack-tip 
shielding were activated in C50 cements which was attributed to their optimum composition.  
FTIR analysis showed that the C50 cements represented the highest peak intensity for both 
COO− Ca2+ and H2SiO3 indicating a higher degree of crosslinking in this GIC group compared to 
other compositions. The results of the in situ FTIR analysis on setting C50 cements showed that 
the intensity of the COO− Ca2+ peak gradually increased over time at the expense of the COOH 
peak which was an indication of a well-performed acid-base reaction in this GIC. 
It was also reported that the bimodal particle size distribution of the solid component in the 
C50 cements might have contributed to their high packing density and structural integrity after 
setting where smaller particles mostly take part in the setting reaction while larger particles 
participate in strengthening mechanisms e.g. crack deflection.  
6.2 Contributions to Knowledge 
Each stage of this study has produced novel contributions which all combine to allow for 
improvement of mechanical and biomineralizing properties of glass ionomer cements doped with 
45S5 Bioglass®-ceramic particles. The idea of crystallization of the Bioglass® and incorporating it 
in glass-ceramic form can be usefully applied to other biomaterials e. g. bone cements, scaffolds, 
and implants. The results obtained from the Bioglass® thermal analysis can definitely help in 
understanding the Bioglass® crystallization behavior. The produced hybrid GIC with enhanced 
mechanical and remineralizing performance can potentially gain wide clinical interest. Being Al-
free while acquiring the required standard mechanical properties, the novel 45S5 Bioglass®-based 
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GIC developed in the last chapter of this research can be a promising material as dental restorative 
and/or bone cement. The details of the contributions of the current research are explained below. 
For the first time it was demonstrated that a comprehensive set of heat treatment regimes 
can be developed to accurately crystallize the Bioglass® to the desired degree of crystallization of 
combeite to obtain a mechanically strong yet bioactive phase. Depending on the target application, 
different levels of mechanical and remineralizing properties may be required. The crystallinity of 
45S5 Bioglass® can be tailored from 5% to 95% by applying the appropriate heat treatment regime 
selected from the profiles developed in this study. Also, the detailed experimental methodology 
designed for studying the thermal and crystallization behavior of the Bioglass® can be used for 
similar bioactive glasses.  
For the first time, a modified hybrid GIC with improved mechanical and remineralizing 
properties was produced by incorporation of an optimum amount (5 wt%) of 45S5 Bioglass®-
ceramic containing optimum combeite crystallinity (74%). Based on the literature, previously 
developed GIC containing bioglasses, severely lack compressive strength and also cement 
integrity. The hybrid GIC produced in this study benefit from a compressive strength higher than 
the commercially available GIC. The understanding of the fact that sufficient amounts of 
crystallized phase (i.e. combeite) and the amorphous phosphorous-rich phase are both needed for 
the glass-ceramic to effectively partake in the setting process and form an excellent interfacial 
bond with the GIC matrix can help in the design of the microstructure and properties of the hybrid 
GICs produced. A widespread investigation on the in vitro behavior of the hybrid GICs as well as 
the effective strengthening mechanisms leading to their prominent mechanical performance were 
also described. Such hybrid GICs can potentially offer improved in vivo performance with broad 
clinical applications. 
The development of an Al-free GICs using 45S5 Bioglass® and its corresponding 
Bioglass®-ceramic with standard mechanical properties is another major contribution of this study. 
For the first time additions of a bioactive glass as the only solid component of GICs was 
investigated. The 45S5 glass-ceramic particles with 74% crystallinity were used for this purpose 
as they can best act as both remineralizing and reinforcing agents. In these GICs, the neurotoxic 
effects of Al are avoided while chemical bonds are expected to form between the GIC and the 
surrounding hard tissue(s) through interfacial biomineralization and adhesion.   
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6.3 Future work 
The following suggestions are proposed as future work to expand further the current study: 
❖ The comprehensive set of heat treatment regimes presented in chapter 3 provides the 
possibility of producing mechanically strong Bioglass®-ceramics with appropriate 
degree of crystallinity suitable for various applications (e.g. bone cements). The same 
experimental approach used in this study can be employed to improve mechanical and 
remineralizing properties of bone cements.  
❖ In vitro cell tests, in vivo tests and clinical studied should be performed on GICs 
developed in this research to further evaluate their biocompatibility as well as their 
mechanical performance in-service. 
❖ It is suggested to study the adhesion properties (e.g. shear bond strength to dentin) of 
the GICs developed in this research.  
❖ It would be interesting to conduct a similar research utilizing commercially available 
bioglasses other than 45S5 Bioglass® and compare the results. 
❖ 45S5 Bioglass® and Bioglass®-ceramic used in this research were in the powder form. 
It would be interesting to see the result when they are used in other forms e.g. fiber, 
microfibers, nanoparticles, etc.  
❖ Bimodal distribution of the Bioglass® and Bioglass®-ceramic was shown to affect the 
mechanical performance of the GICs. It is suggested to study the effect of particle size 
of the Bioglass®-ceramic on the mechanical and setting properties of the GICs 
developed in this study. 
❖ It would be worth examining the addition of an optimized amount of a chelating agent 
to the liquid component of the Al-free GIC to better control the setting reaction and 
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